Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 2.7.1.199 - protein-Npi-phosphohistidine-D-glucose phosphotransferase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
22q11 Deletion Syndrome
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Abetalipoproteinemia
Laboratory investigations.
Abortion, Spontaneous
Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction.
Abscess
Mechanisms regulating skeletal muscle glucose metabolism in sepsis.
Acidosis
Effects of Creatine Treatment on Jejunal Phenotypes in a Rat Model of Acidosis.
Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.
Microarray analysis of PBMC after Plasmodium falciparum infection: Molecular insights into disease pathogenesis.
Proteomic Profiling of the Effect of Metabolic Acidosis on the Apical Membrane of the Proximal Convoluted Tubule.
Acidosis, Lactic
Neuroprotection conferred by post-ischemia ethanol therapy in experimental stroke: an inhibitory effect on hyperglycolysis and NADPH oxidase activation.
Acquired Immunodeficiency Syndrome
Trehalose limits opportunistic mycobacterial survival during HIV co-infection by reversing HIV-mediated autophagy block.
Acute Kidney Injury
Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption.
Adenocarcinoma
Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1?, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
Association between 18F-fluorodeoxyglucose-PET/CT and histological grade of uterine endometrial carcinoma.
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.
Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas.
Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.
Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma.
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma.
Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation.
Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia.
Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma.
Operable Non-Small Cell Lung Cancer: Correlation of Volumetric Helical Dynamic Contrast-enhanced CT Parameters with Immunohistochemical Markers of Tumor Hypoxia.
Significance of Glucose Transporter Type 1 (GLUT-1) Expression in the Therapeutic Strategy for Pancreatic Ductal Adenocarcinoma.
Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.
[Expression of glucose transporter protein 1 and desmin in reactive mesothelial hyperplasia and epithelioid malignant mesothelioma].
¹?F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
Adenocarcinoma of Lung
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma.
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth.
Down-Regulation of Hypoxia-Inducible Factor-1? and Downstream Glucose Transporter Protein-1 Gene by ?-elemene Enhancing the Radiosensitivity of Lung Adenocarcinoma Transplanted Tumor.
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Low glucose transporter SLC2A5-inhibited human normal adjacent lung adenocarcinoma cytoplasmic pro-B cell development mechanism network.
MicroRNA-6077 enhances the sensitivity of patients-derived lung adenocarcinoma cells to anlotinib by repressing the activation of glucose transporter 1 pathway.
Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.
Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.
Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.
Adenocarcinoma, Mucinous
The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma.
Adenoma
Both butyrate incubation and hypoxia upregulate genes involved in the ruminal transport of SCFA and their metabolites.
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
Characteristics of benign adrenocortical adenomas with 18F-FDG PET accumulation.
Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis.
MicroRNA Expression Profile Reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer.
Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis.
[Significant increase of glucose transport activity in breast cancer]
Adenoma, Islet Cell
Abnormal facilitative glucose transporter gene expression in human islet cell tumors.
Glucose transporter proteins in human insulinoma.
Adenoma, Liver Cell
Hepatocellular adenoma showing high uptake of (18)F-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2).
Adenoma, Pleomorphic
Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas.
Adenoviridae Infections
Maintaining HNF6 expression prevents AdHNF3beta-mediated decrease in hepatic levels of Glut-2 and glycogen.
Adrenocortical Carcinoma
Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
Oncocytic Adrenocortical Carcinoma With Low 18F-FDG Uptake and the Absence of Glucose Transporter 1 Expression.
Adrenoleukodystrophy
[Dietary advice for treatment of inborn errors of metabolism in adult neurology: principes and limitations]
Albuminuria
[Managing diabetic kidney disease].
Altitude Sickness
Overexpression of genes associated with hypoxia in cattle adapted to Trans Himalayan region of Ladakh.
Alzheimer Disease
Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer's disease.
Akt and cAMP response element binding protein mediate 17?-estradiol regulation of glucose transporter 3 expression in human SH-SY5Y neuroblastoma cell line.
Blood-brain barrier abnormalities in Alzheimer's disease.
Changes in the glucose transporter of brain capillaries.
Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.
CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease.
Expression of the glucose transporter GLUT12 in Alzheimer's disease patients.
Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone.
Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease.
Indices of metabolic dysfunction and oxidative stress.
Long-term Oral Galactose Treatment Prevents Cognitive Deficits in Male Wistar Rats Treated Intracerebroventricularly with Streptozotocin.
Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease.
Reduced glucose transporter concentrations in brains of patients with Alzheimer's disease.
The blood-brain and gut-vascular barriers: from the perspective of claudins.
[Immunohistochemistry using antibody to the glucose transporter 3 in human brainstem and cerebellar tissues]
Ameloblastoma
Glucose Transporter 1 Expression in Odontogenic Keratocyst, Dentigerous Cyst, and Ameloblastoma: An Immunohistochemical Study.
Anemia
Anemia in Glucose Transporter Type 1 Deficiency Syndrome: Often Expected, Rarely Encountered, and with a Fascinating Explanation.
Anemia, Hemolytic
Atypical Manifestations in Glut1 Deficiency Syndrome.
Aneurysm
Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.
Medial Hypoxia and Adventitial Vasa Vasorum Remodeling in Human Ascending Aortic Aneurysm.
Apraxias
Atypical Manifestations in Glut1 Deficiency Syndrome.
Arthritis
Alterations in adipocyte glucose transporter GLUT4 and circulating adiponectin and visfatin in rat adjuvant induced arthritis.
Arthritis, Experimental
Alterations in adipocyte glucose transporter GLUT4 and circulating adiponectin and visfatin in rat adjuvant induced arthritis.
Arthritis, Rheumatoid
Glucose transporter 1 in rheumatoid arthritis and autoimmunity.
Influence of genetic copy number variants of the human GLUT3 glucose transporter gene SLC2A3 on protein expression, glycolysis and rheumatoid arthritis risk: A genetic replication study.
Astrocytoma
Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.
Distribution of the glucose transporters in human brain tumors.
The erythrocyte-type glucose transporter in blood vessels of primary and metastatic brain tumors.
The glucose transporter and blood-brain barrier of human brain tumors.
Ataxia
A three-year-old boy with glucose transporter type 1 deficiency syndrome presenting with episodic ataxia.
Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
First report of glucose transporter 1 deficiency syndrome in Korea with a novel splice site mutation.
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Glucose Transporter Type 1 Deficiency Syndrome: Developmental Delay and Early-Onset Ataxia in a Novel Mutation of the SLC2A1 Gene.
Glucose transporter type 1 deficiency: Ketogenic diet in three patients with atypical phenotype.
Intermittent Ataxia with Early Onset Absence Epilepsy in Glucose Transporter Type 1 Deficiency Syndrome.
Laboratory investigations.
Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome.
Ataxia Telangiectasia
ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt.
Atherosclerosis
Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis.
Avitaminosis
Laboratory investigations.
Bile Duct Neoplasms
Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Biotinidase Deficiency
Actual Insights into Treatable Inborn Errors of Metabolism Causing Epilepsy.
Brain Diseases
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Disease-associated Glut1 single amino acid substitute mutations S66F, R126C, and T295M constitute Glut1-deficiency states in vitro.
Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro.
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Glucose metabolism transporters and epilepsy: only GLUT1 has an established role.
Glucose transporter 1 deficiency syndrome and hemiplegic migraines as a dominant presenting clinical feature.
Glucose transporter 1 deficiency syndrome and other glycolytic defects.
GLUT-1 deficiency presenting with seizures and reversible leukoencephalopathy on MRI imaging.
GLUT1 deficiency links nutrient availability and apoptosis during embryonic development.
Impaired glucose transport into the brain: the expanding spectrum of glucose transporter type 1 deficiency syndrome.
Sweet and low-autoantibodies deny oligodendrocytes their sugar fix.
The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome.
Brain Diseases, Metabolic
A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome.
A three-year-old boy with glucose transporter type 1 deficiency syndrome presenting with episodic ataxia.
GLUT1-deficiency syndrome: Report of a four-generation Norwegian family with a mild phenotype.
Occurrence of GLUT1 deficiency syndrome in patients treated with ketogenic diet.
Brain Edema
Expression of GLUT3 and HIF-1? in Meningiomas of Various Grades Correlated with Peritumoral Brain Edema.
Brain Injuries
Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats.
Glut1 glucose transporter activity in human brain injury.
Hypoxic-ischemic brain injury exacerbates neuronal apoptosis and precipitates spontaneous seizures in glucose transporter isoform 3 heterozygous null mice.
Brain Injuries, Traumatic
Glut1 glucose transporter activity in human brain injury.
Increased expression of neuronal glucose transporter 3 but not glial glucose transporter 1 following severe diffuse traumatic brain injury in rats.
Lactate and its many faces.
Brain Ischemia
Aged garlic extract and S-allylcysteine increase the GLUT3 and GCLC expression levels in cerebral ischemia.
Cerebral ischemia affects glucose transporter kinetics across rat brain microvascular endothelium: quantitative analysis by an in situ brain perfusion method.
Cerebral ischemia alters glucose transporter kinetics across rat brain microvascular endothelium. Quantitative analysis by an in situ brain perfusion method.
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
Inducible astrocytic glucose transporter-3 contributes to the enhanced storage of intracellular glycogen during reperfusion after ischemia.
Progressive hippocampal loss of immunoreactive GLUT3, the neuron-specific glucose transporter, after global forebrain ischemia in the rat.
Brain Neoplasms
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer.
Distribution of the glucose transporters in human brain tumors.
Expression of facilitative glucose transporter isoforms in human brain tumors.
Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating.
Mitochondrial control by DRP1 in brain tumor initiating cells.
Site-directed deletion of a 10-nucleotide domain of the 3'-untranslated region of the GLUT1 glucose transporter mRNA eliminates cytosolic protein binding in human brain tumors and induction of reporter gene expression.
The erythrocyte-type glucose transporter in blood vessels of primary and metastatic brain tumors.
The glucose transporter and blood-brain barrier of human brain tumors.
Vascular expression of glucose transporter in experimental brain neoplasms.
Breast Neoplasms
Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes.
AKT-dependent sugar addiction by benzyl isothiocyanate in breast cancer cells.
Biological characterisation of breast cancer by means of PET.
Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin.
Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer.
Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma.
Clinicopathological and prognostic significance of GLUT1 in breast cancer: A meta-analysis.
Co-expression and prognosis analyses of GLUT1-4 and RB1 in breast cancer.
Detection of human breast cancer cells using a 2-deoxy-D-glucose-functionalized superparamagnetic iron oxide nanoparticles.
Diagnostic potential of hypoxia-induced genes in liquid biopsies of breast cancer patients.
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer.
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype.
Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells.
Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death.
Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.
Expression of glucose transporter GLUT-1 and estrogen receptors ER-alpha and ER-beta in human breast cancer.
Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
Fatty acid-bearing albumin but not fatty acid-depleted albumin induces HIF-1 activation in human renal proximal tubular epithelial cell line HK-2.
Glucose erythrocyte transporter in women with breast cancer: changes in lipid composition of erythrocyte membrane.
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain.
Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions.
Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
Glut-1 Expression Correlates with Basal-like Breast Cancer.
GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
GLUT1 participates in tamoxifen resistance in breast cancer cells through autophagy regulation.
GLUT12 and adipose tissue: Expression, regulation and its relation with obesity in mice.
Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer.
Glycopolymer decorated multiwalled carbon nanotubes for dual targeted breast cancer therapy.
Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
Identification of a novel glucose transporter-like protein-GLUT-12.
Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes.
Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.
Immunohistochemical expression of melatonin receptor MT1 and glucose transporter GLUT1 in human breast cancer.
Impact of a high-cholesterol diet on expression levels of Niemann-Pick C1-like 1 and intestinal transporters in rats and mice.
Increased expression of mitochondrial sodium-coupled ascorbic acid transporter-2 (mitSVCT2) as a central feature in breast cancer.
Influence of cycloheximide-mediated downregulation of glucose transport on TNF alpha-induced apoptosis.
Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5.
Inhibition of miRNA-34a promotes triple negative cancer cell proliferation by promoting glucose uptake.
Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells.
Loss of GLUT4 Induces Metabolic Reprogramming and Impairs Viability of Breast Cancer Cells.
miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.
Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.
Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment.
Pioglitazone induces hypoxia-inducible factor 1 activation in human renal proximal tubular epithelial cell line HK-2.
Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset.
Role for glucose transporter 1 protein in human breast cancer.
Self-assembled levan nanoparticles for targeted breast cancer imaging.
Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer.
Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1? expression.
The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter.
The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers.
The XbaI G>T polymorphism of the glucose transporter 1 gene modulates 18F-FDG uptake and tumor aggressiveness in breast cancer.
Tumor stiffness measured by shear wave elastography correlates with tumor hypoxia as well as histologic biomarkers in breast cancer.
Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines.
[Expression of glucose transporter 1 in human breast carcinoma and its clinical significance]
[Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells].
[Significant increase of glucose transport activity in breast cancer]
[Uptake of 2-NBDG by human breast cancer cells in vitro].
Calcinosis
The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.
Carcinogenesis
Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.
Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.
Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas.
Complex regulation of simple sugar transport in insulin-responsive cells.
Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing.
Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members, obese and non-obese controls - a preliminary report.
Glucose transporter 3 performs a critical role in mTOR-mediated oncogenic glycolysis and tumorigenesis.
Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells.
GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4.
Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3.
Carcinoma
18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
An analysis of the polymorphisms of the GLUT1 gene in urothelial cell carcinomas of the bladder and its correlation with p53, Ki67 and GLUT1 expressions.
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
Coexpression of hypoxia-inducible factor-1? and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Construction of a GLUT-1 and HIF-1? gene knockout cell model in HEp-2 cells using the CRISPR/Cas9 technique.
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
Correspondence re: Ito T, Noguchi Y, Satoh S, Hayashi H, Inayama Y, Kitamura H: Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Mod Pathol 1998; 11:437-443.
Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method.
Diagnostic Value of Glucose Transporter 1 (GLUT-1) Expression in Nested Variant of Urothelial Carcinoma.
Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Effect of methylxanthine derivatives on doxorubicin transport and antitumor activity.
Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.
Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.
Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary.
Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract.
Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI.
Glucose transporter 1 (GLUT1) expression is associated with intestinal type of gastric carcinoma.
Glucose Transporter 1 Overexpression in Oral Squamous Cell Carcinoma.
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer.
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters.
Glucose transporter expression in developing fetal lungs and lung neoplasms.
Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions.
Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
GLUT-1 staining of squamous cell carcinomas of the uterine cervix identifies a novel element of invasion.
GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer.
Glycolysis-related protein expression in thyroid cancer.
Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.
HIF-1? and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
High Expression of Glucose Transporter 1 on Primary Lesions of Esophageal Squamous Cell Carcinoma is Associated with Hematogenous Recurrence.
High-grade transformation of adenoid cystic carcinomas: a study of the expression of GLUT1 glucose transporter and of mitochondrial antigen.
Histological and immunohistochemical evaluation of stroma variations and their correlation with the Ki-67 index and expressions of glucose transporter 1 and monocarboxylate transporter 1 in canine thyroid C-cell carcinomas.
Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.
Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas.
Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.
Inhibition of microRNA-218 promotes oral squamous cell carcinoma growth by targeting GLUT1 to affect glucose metabolism.
Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
LncRNA-SNHG16 Silencing Inhibits Prostate Carcinoma Cell Growth, Downregulate GLUT1 Expression and Reduce Glucose Uptake.
Long non-coding RNA mortal obligate RNA transcript suppresses tumor cell proliferation in prostate carcinoma by inhibiting glucose uptake.
Lung Cancer: A Comparative Study of Metabolism Related Protein Expression in Cancer Cells and Tumor Associated Stroma.
Lung squamous cell carcinoma exhibits a targetable glucose dependency unique among non-small cell lung cancers.
MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis.
miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.
Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In Vivo.
Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy.
Molecular typing of epithelial ovarian carcinomas using inflammatory markers.
NAMPT is the cellular target of STF-31-like small-molecule probes.
Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis.
Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.
Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis.
Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies.
Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma.
Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis.
Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy.
Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer.
Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas.
The blood-brain and gut-vascular barriers: from the perspective of claudins.
The facilitative glucose transporter GLUT3: 20 years of distinction.
The impact of N- and O-glycosylation on the functions of Glut-1 transporter in human thyroid anaplastic cells.
The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
The Rep68 protein of adeno-associated virus type 2 stimulates expression of the platelet-derived growth factor B c-sis proto-oncogene.
The significance of detecting glucose transporter 1 and calretinin in serous effusions to differentiate between carcinoma cells and reactive mesothelial cells.
Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.
Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression.
Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
[Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis.]
[Expression of glucose transporter 1 in human laryngeal squamous cell carcinoma and its clinical significance].
[Expression of glucose transporter in non-small cell lung carcinoma and its clinical significance]
[Expression of hypoxia inducible factor-1? and correlated target genes in human laryngeal carcinoma].
[Inhibition of Sirolimus on the growth of pancreatic carcinoma and its effect on the expression of glucose transporter and hexokinase ?].
Carcinoma, Adenoid Cystic
High-grade transformation of adenoid cystic carcinomas: a study of the expression of GLUT1 glucose transporter and of mitochondrial antigen.
Carcinoma, Ductal
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer.
Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
Carcinoma, Ehrlich Tumor
Increases in mRNA levels of glucose transporters types 1 and 3 in Ehrlich ascites tumor cells during tumor development.
Carcinoma, Hepatocellular
18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
A study of the regulation of the glucose transporter in the plasma membranes of hepatoma cells induced by 3'-Me DAB.
Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism.
C/EBP binding activity to site F of the rat GLUT2 glucose transporter gene promoter is attenuated by c-Jun in vitro.
Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced ?-catenin activation.
CCAAT/enhancer binding protein regulates the promoter activity of the rat GLUT2 glucose transporter gene in liver cells.
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation.
Diacylglycerol kinase ? predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma.
Distribution of glucose transporter messenger RNA transcripts in tissues of rat and man.
Elevation of facilitated glucose-transporter messenger RNA in human hepatocellular carcinoma.
Escherichia coli kgtP encodes an alpha-ketoglutarate transporter.
Evidence for expression of the facilitated glucose transporter in rat hepatocytes.
Expression of the human erythrocyte glucose transporter in Escherichia coli.
FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells.
Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma.
Insulin action on activity and cell surface disposition of human HepG2 glucose transporters expressed in Chinese hamster ovary cells.
Pattern of glucose transporter (Glut 1) expression in embryonic brains is related to maturation of blood-brain barrier tightness.
Prognostic value of glucose transporter 3 expression in hepatocellular carcinoma.
Quantitative immunocytochemistry (image analysis) of glucose transporters in the normal and postischemic rodent hippocampus.
Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis.
Regulation of glucose transporter-specific mRNA levels in rat adipose cells with fasting and refeeding. Implications for in vivo control of glucose transporter number.
Role of the GLUT 2 glucose transporter in the response of the L-type pyruvate kinase gene to glucose in liver-derived cells.
RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Tissue-specific and de novo promoter methylation of the mouse glucose transporter 2.
Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).
Carcinoma, Intraductal, Noninfiltrating
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer.
Carcinoma, Medullary
Glycolysis-related protein expression in thyroid cancer.
Carcinoma, Mucoepidermoid
Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy.
Carcinoma, Non-Small-Cell Lung
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Circular RNA MYLK Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer Cells by Sponging miR-195-5p and Increasing Glucose Transporter Member 3 Expression.
Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.
Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer.
Correlation of Glut-1 glucose transporter expression with.
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin ?1/Src/FAK Signaling.
Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection.
Lung squamous cell carcinoma exhibits a targetable glucose dependency unique among non-small cell lung cancers.
Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Prognostic significance of genetic variants in GLUT1 in stage III non-small cell lung cancer treated with radiotherapy.
Relationship between (18)F-FDG uptake on PET and various biologic molecular markers in benign pulmonary lesion: comparison with primary lung cancer.
The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
[Expression of glucose transporter in non-small cell lung carcinoma and its clinical significance]
Carcinoma, Pancreatic Ductal
Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
Carcinoma, Renal Cell
A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.
Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method.
Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters.
Glucose transporter polymorphisms are associated with clear-cell renal carcinoma.
Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications.
NAMPT is the cellular target of STF-31-like small-molecule probes.
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer.
Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
Carcinoma, Squamous Cell
18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
GLUT-1 staining of squamous cell carcinomas of the uterine cervix identifies a novel element of invasion.
Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.
Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
Lung squamous cell carcinoma exhibits a targetable glucose dependency unique among non-small cell lung cancers.
Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis.
Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis.
Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy.
Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Carcinoma, Transitional Cell
Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.
Cardiomegaly
Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis.
Ginsenoside Rb1 improves cardiac function and remodeling in heart failure.
Glucose transporter 4 (GLUT4) deficient hearts develop maladaptive hypertrophy in response to physiologic or pathologic stresses.
Insulin resistance and altered glucose transporter 4 expression in experimental uremia.
Cardiomyopathies
SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy.
Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.
Cardiomyopathy, Dilated
Cardiac PPARalpha expression in patients with dilated cardiomyopathy.
Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy.
Cardiovascular Diseases
Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia-Induced Neovascularization: The Role of Dipeptidyl Peptidase-4/Glucagon-Like Peptide-1-Adiponectin Axis.
Effects of glucose and insulin on the H9c2 (2-1) cell proliferation may be mediated through regulating glucose transporter 4 expression.
SGLT2 inhibitors and the changing landscape for treatment of diabetes.
Cataract
Another Case of Glucose Transporter 1 Deficiency Syndrome with Periventricular Calcification, Cataracts, Hemolysis, and Pseudohyperkalemia.
cathepsin d deficiency
Metabolic epilepsies: approaches to a diagnostic challenge.
Cerebral Amyloid Angiopathy
Amyloid deposition in cerebrovascular angiopathy.
Cerebral Hemorrhage
Analysis of glucose metabolism by 18F-FDG-PET imaging and glucose transporter expression in a mouse model of intracerebral hemorrhage.
[Expression of glucose transporter 1 in the blood-brain barrier around hematoma in rats with cerebral hemorrhage]
Cerebral Infarction
The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes.
Cerebrovascular Disorders
Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease.
Cervical Intraepithelial Neoplasia
Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
Cholangiocarcinoma
Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas.
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma.
Cholera
Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes.
The regulation of glucose transporter gene expression by cyclic adenosine monophosphate in NIH3T3 fibroblasts.
Chondroblastoma
False positive (18)F-FDG PET in an ischial chondroblastoma; an analysis of glucose transporter 1 and hexokinase II expression.
Choriocarcinoma
Adenoviral-Mediated Placental Gene Transfer of IGF-1 Corrects Placental Insufficiency via Enhanced Placental Glucose Transport Mechanisms.
Hyperglycemia regulates the glucose-transport system of clonal choriocarcinoma cells in vitro. A potential molecular mechanism contributing to the adjunct effect of glucose in tumor therapy.
Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1.
Transepithelial glucose transport and metabolism in BeWo choriocarcinoma cells.
Coccidiosis
Impacts of increasing challenge with Eimeria maxima on the growth performance and gene expression of biomarkers associated with intestinal integrity and nutrient transporters.
Colonic Neoplasms
Downregulation of lncRNA AWPPH inhibits colon cancer cell proliferation by downregulating GLUT-1.
Evaluation of [18F]FDG/[18F]FLT/[18F]FMISO-based micro-positron emission tomography in detection of liver metastasis in human colorectal cancer.
Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras.
Knockdown of Hypoxia-Inducible Factor 1? Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts.
Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice.
Overexpression of miRNA-143 Inhibits Colon Cancer Cell Proliferation by Inhibiting Glucose Uptake.
Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms.
Sequence and structure of a human glucose transporter.
Colorectal Neoplasms
Apple Polyphenol Phloretin Inhibits Colorectal Cancer Cell Growth via Inhibition of the Type 2 Glucose Transporter and Activation of p53-Mediated Signaling.
Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis.
HMGA1 Promotes Hepatic Metastasis of Colorectal Cancer by Inducing Expression of Glucose Transporter 3 (GLUT3).
Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis.
Relations of TGF-beta1 with HIF-1alpha, GLUT-1 and longer survival of colorectal cancer patients.
RPS7 inhibits colorectal cancer growth via decreasing HIF-1?-mediated glycolysis.
Targeting Colorectal Cancer with Conjugates of a Glucose Transporter Inhibitor and 5-Fluorouracil.
Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
[Expression of hypoxia-inducible factor 1?, glucose transporter 1 and lactate dehydrogenase 5 in colorectal cancer and clinicopathologic significance].
Congenital Abnormalities
Fanconi-Bickel syndrome--a congenital defect of the liver-type facilitative glucose transporter. SSIEM Award. Society for the Study of Inborn Errors of Metabolism.
The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function.
Congenital Disorders of Glycosylation
Neonatal hypoglycaemia: aetiologies.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Actual Insights into Treatable Inborn Errors of Metabolism Causing Epilepsy.
Fanconi-Bickel syndrome: GLUT2 mutations associated with a mild phenotype.
Neonatal hypoglycaemia: aetiologies.
Coronary Artery Disease
Title: Coronary artery disease is associated with higher epicardial Renitol binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue.
Coronary Occlusion
Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction.
COVID-19
Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19.
Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients.
Craniopharyngioma
Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study.
Cryptorchidism
Degenerative changes in spermatogonia are associated with loss of glucose transporter (Glut 3) in abdominal testis of surgically induced unilateral cryptorchidism in rats.
Cystic Fibrosis
Cl- channels regulate lipid droplet formation via Rab8a expression during adipocyte differentiation.
Identification of the cofilin-binding sites in the large cytoplasmic domain of Na,K-ATPase.
Role of membrane trafficking in plasma membrane solute transport.
Cysts
Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.
Bilateral multiple oncocytic cysts of the parotid gland in type 2 diabetes patients.
Hypoxia-inducible factor-1? causes renal cyst expansion through calcium-activated chloride secretion.
Use of a murine embryonic stem cell line that is sensitive to high glucose environment to model neural tube development in diabetic pregnancy.
Death, Sudden, Cardiac
Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia.
Dementia
Long-term Oral Galactose Treatment Prevents Cognitive Deficits in Male Wistar Rats Treated Intracerebroventricularly with Streptozotocin.
Loss with ageing but preservation of frontal cortical capillary pericytes in post-stroke dementia, vascular dementia and Alzheimer's disease.
Dental Caries
Association of GLUT2 and TAS1R2 Genotypes with Risk for Dental Caries.
GLUT2 and TAS1R2 Polymorphisms and Susceptibility to Dental Caries.
Dentigerous Cyst
Glucose Transporter 1 Expression in Odontogenic Keratocyst, Dentigerous Cyst, and Ameloblastoma: An Immunohistochemical Study.
Diabetes Complications
Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; Evidence from Kurdish patients with type 2 diabetes mellitus.
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice.
Glucose transport in brain and retina: implications in the management and complications of diabetes.
Diabetes Mellitus
(+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice.
A mathematical model and computer simulation study of insulin sensitive glucose transporter regulation.
A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus.
A study of mRNA expression of glucose transporter gene in rats with diabetes mellitus.
Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking.
An Intron Variant of SLC2A9 Increases the Risk for Type 2 Diabetes Mellitus Complicated with Hyperuricemia in Chinese Male Population.
Analysis of three glucose transporter genes in a Caucasian population: no associations with non-insulin-dependent diabetes and obesity.
Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus.
Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat.
Antioxidant and anti-inflammatory properties of gamma- oryzanol attenuates insulin resistance by increasing GLUT- 4 expression in skeletal muscle of obese animals.
Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families.
Association between a restriction fragment length polymorphism at the liver/islet cell (GluT 2) glucose transporter and familial type 2 (non-insulin-dependent) diabetes mellitus.
Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific.
Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; Evidence from Kurdish patients with type 2 diabetes mellitus.
Associations between the HaeIII Single Nucleotide Polymorphism in the SLC2A1 Gene and Diabetic Nephropathy in Korean Patients with Type 2 Diabetes Mellitus.
Betaine ameliorates impaired steroidogenesis and apoptosis in mice granulosa cells induced by high glucose concentration.
Bioactive compounds in plant materials for the prevention of diabetesand obesity.
CASE FINDING FOR HYPOTHYROIDISM SHOULD INCLUDE TYPE 2 DIABETES AND METABOLIC SYNDROME PATIENTS: A LATIN AMERICAN THYROID SOCIETY (LATS) POSITION STATEMENT.
Changes in Expression of Follicular Glucose Transporters May Be Involved in Ovarian Function Impairment during Diabetic Hyperglycemia.
Diabetes mellitus induces long lasting changes in the glucose transporter of rat heart endothelial cells.
Diabetes Modulates MicroRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p Expression in Muscle: Possible Role in GLUT4 and HK2 Repression.
Diabetic nephropathy: newer therapeutic perspectives.
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors.
Effect of pomegranate seed oil supplementation on the GLUT-4 gene expression and glycemic control in obese people with type 2 diabetes: A randomized controlled clinical trial.
Effect of sodium-dependent glucose transporter inhibitors on glycated hemoglobin A1c after 24?weeks in patients with diabetes mellitus: A systematic review and meta-analysis.
Empagliflozin Ameliorates Type 2 Diabetes-Induced Ultrastructural Remodeling of the Neurovascular Unit and Neuroglia in the Female db/db Mouse.
Exploring newer target sodium glucose transporter 2 for the treatment of diabetes mellitus.
Expression of Glucose Transporter 4 (GLUT4) is Increased by Cinnamaldehyde in C2C12 Mouse Muscle Cells.
Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes.
Failure to detect Glut4-Ile383 and IR-Gln1152 variants in NIDDM (non-insulin dependent diabetes mellitus) and control subjects in an Italian population.
Genetic polymorphisms at the human liver/islet glucose transporter (GLUT2) gene locus in Caucasian and West Indian subjects with type 2 (non-insulin-dependent) diabetes mellitus.
Glucose transport in brain and retina: implications in the management and complications of diabetes.
Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a).
Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice.
GLUT3 glucose transporter isoform in rat testis: localization, effect of diabetes mellitus, and comparison to human testis.
GLUT4 Gene Polymorphisms and Their Association with Type 2 Diabetes in South Indians.
Hyperbaric Oxygen Ameliorates Insulin Sensitivity by Increasing GLUT4 Expression in Skeletal Muscle and Stimulating UCP1 in Brown Adipose Tissue in T2DM Mice.
Identification of two novel amino acid polymorphisms in beta-cell/liver (GLUT2) glucose transporter in Japanese subjects.
Impact of pre-gestational and gestational diabetes mellitus on the expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 in human term placenta.
Implications of the CANVAS Study in Reducing Cardiovascular Outcomes.
Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization.
Influence of metformin on GLUT1 gene and protein expression in rat streptozotocin diabetes mellitus model.
Insulin and glucose-dependent regulation of the glucose transport system in the rat L6 skeletal muscle cell line.
Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle.
Insulin-responsive glucose transporter expression in renal microvessels and glomeruli.
Interleukin-18 (rs187238) and glucose transporter 4 (rs5435) polymorphisms in Euro-Brazilians with type 1 diabetes.
Intestinal D-glucose transport and membrane fluidity along crypt-villus axis of streptozocin-induced diabetic rats.
Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus.
Linkage analysis of the genetic markers of the candidate genes with non-insulin dependent diabetes mellitus in Chinese families.
Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
Mechanistic evaluation of the effect of sodium-dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamics.
Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus.
Multiple restriction fragment length polymorphisms at the GLUT2 locus: GLUT2 haplotypes for genetic analysis of type 2 (non-insulin-dependent) diabetes mellitus.
Pathological upregulation of inner blood-retinal barrier Glut1 glucose transporter expression in diabetes mellitus.
Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus.
Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients.
Renal glucose transporters: novel targets for hyperglycemia management.
Sequence variations of the pancreatic islet/liver glucose transporter (GLUT2) gene in Japanese subjects with noninsulin dependent diabetes mellitus.
SGLT2 inhibitors and the changing landscape for treatment of diabetes.
Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats.
Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model.
Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes.
Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus.
Targets of tyrosine nitration in diabetic rat retina.
Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
Type-2 diabetes down-regulates glucose transporter proteins and genes of the human blood leukocytes.
Upregulation Of Renal GLUT2 And SGLT2 Is Involved In High-Fat Diet-Induced Gestational Diabetes In Mice.
Zinc and insulin sensitivity.
[Effects of Huanglian Jiedu Decoction on glucose transporter 4 in target tissues of type 2 diabetic rats]
[Studies on the molecular evolution of glucose transporter gene family]
Diabetes Mellitus, Experimental
Altered renal expression of the insulin-responsive glucose transporter GLUT4 in experimental diabetes mellitus.
Blood-brain barrier glucose transporter mRNA is increased in experimental diabetes mellitus.
Diabetes Mellitus, Type 1
A C-peptide complex with albumin and Zn2+ increases measurable GLUT1 levels in membranes of human red blood cells.
A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus.
Adolescents with clinical type 1 diabetes display reduced red blood cell glucose transporter isoform 1 (GLUT1).
Autoantibodies to the GLUT-2 glucose transporter of beta cells in insulin-dependent diabetes mellitus of recent onset.
Changes in Expression of Follicular Glucose Transporters May Be Involved in Ovarian Function Impairment during Diabetic Hyperglycemia.
Cinnamon extract enhances glucose uptake in 3T3-L1 adipocytes and C2C12 myocytes by inducing LKB1-AMP-activated protein kinase signaling.
Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients.
Diabetic nephropathy: newer therapeutic perspectives.
Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors.
Hepatic steatosis in type 1 diabetes.
Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization.
Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus.
Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects.
Interleukin-18 (rs187238) and glucose transporter 4 (rs5435) polymorphisms in Euro-Brazilians with type 1 diabetes.
Reduced beta-cell glucose transporter in new onset diabetic BB rats.
Regulation of glucose transport and expression of GLUT3 transporters in human circulating mononuclear cells: studies in cells from insulin-dependent diabetic and nondiabetic individuals.
Relative importance of cellular uptake and reactive oxygen species for the toxicity of alloxan and dialuric acid to insulin-producing cells.
The effect of intensive insulin therapy on the insulin-regulatable glucose transporter (GLUT4) expression in skeletal muscle in type 1 diabetes.
Diabetes Mellitus, Type 2
(+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice.
A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes.
A xanthene derivative, DS20060511, attenuates glucose intolerance by inducing skeletal muscle-specific GLUT4 translocation in mice.
Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia.
Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking.
Adipose Tissue, Inter-Organ Communication, and the Path to Type 2 Diabetes: The 2016 Banting Medal for Scientific Achievement Lecture.
Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.
Affected sib-pair analysis of the GLUT1 glucose transporter gene locus in non-insulin-dependent diabetes mellitus (NIDDM): evidence for no linkage.
Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa).
An Intron Variant of SLC2A9 Increases the Risk for Type 2 Diabetes Mellitus Complicated with Hyperuricemia in Chinese Male Population.
Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus.
Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus.
Aqueous-Methanol Extracts of Orange-Fleshed Sweet Potato (Ipomoeabatatas) Ameliorate Oxidative Stress and Modulate Type 2 Diabetes Associated Genes in Insulin Resistant C2C12 Cells.
Association between a restriction fragment length polymorphism at the liver/islet cell (GluT 2) glucose transporter and familial type 2 (non-insulin-dependent) diabetes mellitus.
Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific.
Association between the membrane transporter proteins and type 2 diabetes mellitus.
Association of genetic variant of the glucose transporter with non-insulin-dependent diabetes mellitus.
Association of glucose transporter 1 polymorphisms with type 2 diabetes in the Tunisian population.
Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; Evidence from Kurdish patients with type 2 diabetes mellitus.
Association of two synonymous splicing-associated CpG single nucleotide polymorphisms in calpain 10 and solute carrier family 2 member 2 with type 2 diabetes.
Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population.
Associations between the HaeIII Single Nucleotide Polymorphism in the SLC2A1 Gene and Diabetic Nephropathy in Korean Patients with Type 2 Diabetes Mellitus.
BAG6 contributes to glucose uptake by supporting the cell surface translocation of the glucose transporter GLUT4.
Bioactive compounds in plant materials for the prevention of diabetesand obesity.
CASE FINDING FOR HYPOTHYROIDISM SHOULD INCLUDE TYPE 2 DIABETES AND METABOLIC SYNDROME PATIENTS: A LATIN AMERICAN THYROID SOCIETY (LATS) POSITION STATEMENT.
Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus.
Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis.
Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death.
Decreased expression of glucose transporter in muscle from insulin-resistant patients.
Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: evaluation by a simplified quantitative PCR assay.
Defect of an early event of glucose metabolism in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty (OLETF) rat, a non-insulin-dependent diabetes mellitus (NIDDM) model.
Diabetes induces tri-methylation at lysine 9 of histone 3?at Slc2a4 gene in skeletal muscle: A new target to improve glycemic control.
Diabetic nephropathy: newer therapeutic perspectives.
Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors.
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors.
Duodenal sodium/glucose co-transporter 1 expression under fasting conditions is associated with post-load hyperglycemia.
Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats.
Effect of pomegranate seed oil supplementation on the GLUT-4 gene expression and glycemic control in obese people with type 2 diabetes: A randomized controlled clinical trial.
Effect of sodium-dependent glucose transporter inhibitors on glycated hemoglobin A1c after 24?weeks in patients with diabetes mellitus: A systematic review and meta-analysis.
Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats.
Empagliflozin Ameliorates Type 2 Diabetes-Induced Ultrastructural Remodeling of the Neurovascular Unit and Neuroglia in the Female db/db Mouse.
Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload.
Evaluation of SLC2A10 (GLUT10) as a candidate gene for type 2 diabetes and related traits in Finns.
Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM.
Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance.
Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia.
Excess Accumulation of Lipid Impairs Insulin Sensitivity in Skeletal Muscle.
Exercise Increases Glucose Transporter-4 Levels on Peripheral Blood Mononuclear Cells.
Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients.
Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion.
Failure to detect Glut4-Ile383 and IR-Gln1152 variants in NIDDM (non-insulin dependent diabetes mellitus) and control subjects in an Italian population.
Fluidity of insulin action.
Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes.
Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM.
Genetic variation of the GLUT10 glucose transporter (SLC2A10) and relationships to type 2 diabetes and intermediary traits.
Geniposide promotes autophagy to inhibit insulin resistance in HepG2 cells via P62/NF??B/GLUT?4.
Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus.
Glucose transporter 4 gene: association studies pertaining to alleles of two polymorphisms in extremely obese children and adolescents and in normal and underweight controls.
Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain.
Glucose Transporters in Human Renal Proximal Tubular Cells Isolated From the Urine of Patients With Non-Insulin-Dependent Diabetes.
GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population.
GLUT4 Gene Polymorphisms and Their Association with Type 2 Diabetes in South Indians.
Hep-G2 glucose transporter gene polymorphism in Caucasian, black, Hispanic and Japanese patients with NIDDM.
HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects.
High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis.
Homology modeling of GLUT4, an insulin regulated facilitated glucose transporter and docking studies with ATP and its inhibitors.
Hyperbaric Oxygen Ameliorates Insulin Sensitivity by Increasing GLUT4 Expression in Skeletal Muscle and Stimulating UCP1 in Brown Adipose Tissue in T2DM Mice.
Implications of the CANVAS Study in Reducing Cardiovascular Outcomes.
Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.
Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle.
Insulin-induced cortical actin remodeling promotes GLUT4 insertion at muscle cell membrane ruffles.
Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus.
Is it time to think about the sodium glucose co-transporter 2 sympathetically?
Karanjin from Pongamia pinnata induces GLUT4 translocation in skeletal muscle cells in a phosphatidylinositol-3-kinase-independent manner.
Linkage analysis of acute insulin secretion with GLUT2 and glucokinase in Pima Indians and the identification of a missense mutation in GLUT2.
Linkage analysis of GLUT1 (HepG2) and GLUT2 (liver/islet) genes in familial NIDDM.
Linkage analysis of the genetic markers of the candidate genes with non-insulin dependent diabetes mellitus in Chinese families.
Maturity-onset diabetes of the young (MODY).
Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
Mechanistic evaluation of the effect of sodium-dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamics.
Metabolic Control of Type 2 Diabetes by Targeting the GLUT4 Glucose Transporter: Intervention Approaches.
Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus.
Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects.
Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome.
Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
Normal fuel metabolism and alterations in diabetes mellitus.
Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review.
Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM.
Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of non-insulin-dependent diabetes mellitus.
Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM).
Polymorphisms at the GLUT2 (beta-cell/liver) glucose transporter gene and non-insulin-dependent diabetes mellitus (NIDDM): analysis in affected pedigree members.
Post-GLUT-2 defects in beta-cells of non-insulin-dependent diabetic obese rats.
Preservation of GLUT 2 expression in islet beta cells of Kilham rat virus (KRV)-infected diabetes-resistant BB/Wor rats.
Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle.
Rapid and simultaneous detection of multiple mutations by pooled and multiplex single nucleotide primer extension: application to the study of insulin-responsive glucose transporter and insulin receptor mutations in non-insulin-dependent diabetes.
Recovery of glucose-induced insulin secretion in a rat model of NIDDM is not accompanied by return of the B-cell GLUT2 glucose transporter.
Regulation of glucose transport by pioglitazone in cultured muscle cells.
Relationship between muscle fibre composition, glucose transporter protein 4 and exercise training: possible consequences in non-insulin-dependent diabetes mellitus.
Resistance training is medicine: effects of strength training on health.
Restriction site polymorphisms at the human HepG2 glucose transporter gene locus in Caucasian and west Indian subjects with non-insulin-dependent diabetes mellitus.
Risk stratification tools for heart failure in the diabetes clinic.
Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes.
Sequence variations of the pancreatic islet/liver glucose transporter (GLUT2) gene in Japanese subjects with noninsulin dependent diabetes mellitus.
Serum Betatrophin Levels and Clinical Features in Patients With Poorly Controlled Type 2 Diabetes.
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Signaling of the p21-activated kinase (PAK1) coordinates insulin-stimulated actin remodeling and glucose uptake in skeletal muscle cells.
Single-strand conformation polymorphism analysis of the glucose transporter gene GLUT1 in maturity-onset diabetes of the young.
Sirtuin 6, a possible therapeutic target for type 2 diabetes.
Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model.
SNARE Proteins Underpin Insulin-Regulated GLUT4 Traffic.
Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis.
Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes.
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: Impact of the 2020 KDIGO clinical practice guidelines.
Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes.
Structure and mechanism of the mammalian fructose transporter GLUT5.
Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus.
The actin-related p41ARC subunit contributes to p21-activated kinase-1 (PAK1)-mediated glucose uptake into skeletal muscle cells.
The Axin/TNKS complex interacts with KIF3A and is required for insulin-stimulated GLUT4 translocation.
The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis.
The different hypoglycemic effects between East Asian and non-Asian type 2 diabetes patients when treated with SGLT-2 inhibitors as an add-on treatment for metformin: a systematic review and meta-analysis of randomized controlled trials.
The genetic basis of diabetes mellitus.
The Role of SGLT2 Inhibitor on the Treatment of Diabetic Retinopathy.
Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
Upregulation Of Renal GLUT2 And SGLT2 Is Involved In High-Fat Diet-Induced Gestational Diabetes In Mice.
Use of DNA polymorphisms for genetic analysis of non-insulin dependent diabetes mellitus.
Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients.
WNK1 kinase is essential for insulin-stimulated GLUT4 trafficking in skeletal muscle.
[Candidate gene approach in Japanese NIDDM: liver/pancreatic beta cell type glucose transporter (GLUT2)]
[Change of glucose transporter 4 and its influence on glucose and fatty-acid metabolism in type 2 diabetic myocardium]
[Effects of Chinese herbal medicine Yiqi Zengmin formula on expression of glucose transporter 4 in skeletal muscle in type 2 diabetic rats].
[Effects of Huanglian Jiedu Decoction on glucose transporter 4 in target tissues of type 2 diabetic rats]
[Insulin receptor substrate-1 and glucose transporter gene polymorphisms in noninsulin-dependent diabetes mellitus]
[The CHC22 human clathrin heavy chain isoform, intracellular traffic of the glucose transporter GLUT4, and type 2 diabetes]
[The detection of GLUT2 gene mutation by polymerase-chain reaction single stranded conformation polymorphism (PCR-SSCP) method]
Diabetes, Gestational
Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy.
Expression and correlation of sex hormone-binding globulin and insulin signal transduction and glucose transporter proteins in gestational diabetes mellitus placental tissue.
Fine particulate matter (PM2.5), a risk factor of rat gestational diabetes with altered blood glucose and pancreatic GLUT2 expression.
Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight.
High NOV/CCN3 expression during high-fat diet pregnancy in mice affects GLUT3 expression and the mTOR pathway.
The Effect of Zinc Supplementation on Expressed Levels of Peroxisome Proliferator-Activated Receptor Gamma and Glucose Transporter Type 1 Genes in Newborns of Women with Gestational Diabetes Mellitus.
Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus.
Diabetic Cardiomyopathies
Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.
Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes.
Restoration of myocardial glucose uptake with facilitated myocardial glucose transporter 4 translocation contributes to alleviation of diabetic cardiomyopathy in rats after duodenal-jejunal bypass.
Diabetic Ketoacidosis
A Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery.
Corrigendum to A Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery.
Sodium Glucose Transporter 2 Inhibitors and Diabetic Ketoacidosis in Three Patients with Diabetes: Underlying Causation.
Diabetic Nephropathies
A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus.
Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene.
Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; Evidence from Kurdish patients with type 2 diabetes mellitus.
Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients.
Changes in Renal Glucose Transporters in an Animal Model of Metabolic Syndrome.
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy.
Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients.
Diabetic nephropathy: newer therapeutic perspectives.
GLUT1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy.
Increased glucose uptake and metabolism in mesangial cells overexpressing glucose transporter 1 increases interleukin-6 and vascular endothelial growth factor production: role of AP-1 and HIF-1alpha.
Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in db/db mice and high glucose-treated HK-2 cells.
Nonproteinuric progressive diabetic kidney disease.
Podocyte Specific Overexpression of GLUT1 Surprisingly Reduces Mesangial Matrix Expansion in Diabetic Nephropathy in Mice.
Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy.
Prompt apoptotic response to high glucose in SGLT-expressing renal cells.
Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis.
Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats.
Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes.
Sodium glucose transporter-2 inhibition has no renoprotective effects on non-diabetic chronic kidney disease.
Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease.
XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy.
[Managing diabetic kidney disease].
Diabetic Retinopathy
Glucose transport in brain and retina: implications in the management and complications of diabetes.
GLUT1 activity contributes to the impairment of PEDF secretion by the RPE.
Suppression of sodium-dependent glucose uptake by captopril improves high-glucose-induced morphological and functional changes of cultured bovine retinal pericytes.
Diffuse Cerebral Sclerosis of Schilder
Metabolic epilepsies: approaches to a diagnostic challenge.
DiGeorge Syndrome
Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.
Drug Resistant Epilepsy
Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases.
Glucose Transporter 1 Deficiency: A Treatable Cause of Opsoclonus and Epileptic Myoclonus.
Perioperative Management of a Child With Glucose Transporter Type 1 Deficiency Syndrome: A Case Report.
Prospective study of growth and bone mass in Swedish children treated with the modified Atkins diet.
Dyskinesias
Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency.
Atypical Manifestations in Glut1 Deficiency Syndrome.
Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Glucose metabolism transporters and epilepsy: only GLUT1 has an established role.
Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency.
Overall cognitive profiles in patients with GLUT1 Deficiency Syndrome.
Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.
Phenotypic variability of GLUT1 deficiency: When is necessary to suspect?
Dyslipidemias
Effects of neonatal dexamethasone administration on cardiac recovery ability under ischemia-reperfusion in 24 weeks old rats.
Dystonia
Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Dystonic Disorders
The benefits of a Neurogenetics clinic in an adult Academic Teaching Hospital.
Ecchymosis
Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ.
Encephalitis
Dysregulation of sonic hedgehog pathway and pericytes in the brain after lentiviral infection.
Encephalomyelitis
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Encephalomyelitis, Autoimmune, Experimental
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Endometrial Hyperplasia
Immunohistochemical investigation of metabolic markers fatty acid synthase (FASN) and glucose transporter 1 (GLUT1) in normal endometrium, endometrial hyperplasia, and endometrial malignancy.
Endometrial Neoplasms
Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells.
Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma.
GLUT 1 expression is a supportive mean in predicting prognosis and survival estimates of endometrial carcinoma.
LEFTY2/endometrial bleeding-associated factor up-regulates Na+ Coupled Glucose Transporter SGLT1 expression and Glycogen Accumulation in Endometrial Cancer Cells.
Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators.
The NF-?B signalling pathway regulates GLUT6 expression in endometrial cancer.
Endometriosis
Understanding the Role of Gui-Zhi-Fu-Ling-Capsules (Chinese Medicine) for Treatment of Endometriosis in the Rat Model: Using NMR Based Metabolomics.
Endotoxemia
Brief endotoxemia markedly increases expression of GLUT1 glucose transporter in Kupffer, hepatic endothelial and parenchymal cells.
Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.
Eosinophilia
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation.
Epilepsies, Myoclonic
From Genetic Testing to Precision Medicine in Epilepsy.
Glucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy.
Glucose Transporter 1 Deficiency: A Treatable Cause of Opsoclonus and Epileptic Myoclonus.
Neonatal seizures and syndromes.
Novel and de novo mutations in pediatric refractory epilepsy.
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Symptomatic epilepsies imitating idiopathic generalized epilepsies.
Epilepsies, Partial
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Epilepsy
?-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons.
A new mouse model of GLUT1 deficiency syndrome exhibits abnormal sleep-wake patterns and alterations of glucose kinetics in the brain.
Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency.
Acetazolamide-responsive Episodic Ataxia Without Baseline Deficits or Seizures Secondary to GLUT1 Deficiency: A Case Report and Review of the Literature.
Actual Insights into Treatable Inborn Errors of Metabolism Causing Epilepsy.
Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review.
Atypical Manifestations in Glut1 Deficiency Syndrome.
Clinical Application of Targeted Next-Generation Sequencing Panels and Whole Exome Sequencing in Childhood Epilepsy.
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy.
Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
From Genetic Testing to Precision Medicine in Epilepsy.
Genome-wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug-resistant epilepsy.
Glucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy.
Glucose transporter type 1 deficiency due to SLC2A1 gene mutations--a rare but treatable cause of metabolic epilepsy and extrapyramidal movement disorder; own experience and literature review.
Glucose transporter type 1 deficiency syndrome with carbohydrate-responsive symptoms but without epilepsy.
Glucose Transporter Type 1 Deficiency Syndrome: Developmental Delay and Early-Onset Ataxia in a Novel Mutation of the SLC2A1 Gene.
Glucose transporter type I deficiency syndrome: Epilepsy phenotypes and outcomes.
GLUT-1 deficiency presenting with seizures and reversible leukoencephalopathy on MRI imaging.
Impact of the Ketogenic Diet on Linear Growth in Children: A Single-Center Retrospective Analysis of 34 Cases.
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Metabolic epilepsies: approaches to a diagnostic challenge.
Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency.
New GLUT-1 mutation in a child with treatment-resistant epilepsy.
NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges.
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.
Potential therapeutic use of the ketogenic diet in autism spectrum disorders.
Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome.
Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: A 3-month prospective observational study.
Study of paediatric patients with the clinical and biochemical phenotype of glucose transporter type 1 deficiency syndrome.
Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.
The face of Glut1-DS patients: A 3D Craniofacial Morphometric Analysis.
The Many Faces of Glut1 Deficiency Syndrome.
Treatment of myoclonic-atonic epilepsy caused by SLC2A1 de novo mutation with ketogenic diet: A case report.
Use of Remote Monitoring by E-mail for Long-Term Management of the Classic Ketogenic Diet.
Variants in KCNJ11 and BAD do not predict response to ketogenic dietary therapies for epilepsy.
[Dietary therapy of epilepsy].
[Experience of using ketogenic diet in a patient with glucose transporter 1 deficiency syndrome (a case report)].
[Glucose transport hereditary diseases]
[Type 1 glucose transporter (Glut1) deficiency: manifestations of a hereditary neurological syndrome]
Epilepsy, Absence
Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1.
Intermittent Ataxia with Early Onset Absence Epilepsy in Glucose Transporter Type 1 Deficiency Syndrome.
Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.
Treatment of myoclonic-atonic epilepsy caused by SLC2A1 de novo mutation with ketogenic diet: A case report.
Epilepsy, Generalized
Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency.
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Glucose metabolism transporters and epilepsy: only GLUT1 has an established role.
Glucose transporter 1 deficiency in the idiopathic generalized epilepsies.
Glut-1 deficiency syndrome masquerading as idiopathic generalized epilepsy.
Investigation of SLC2A1 gene variants in genetic generalized epilepsy patients with eyelid myoclonia.
Epileptic Syndromes
Neonatal seizures and syndromes.
Treatment of myoclonic-atonic epilepsy caused by SLC2A1 de novo mutation with ketogenic diet: A case report.
Esophageal Neoplasms
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer.
Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.
Esophageal Squamous Cell Carcinoma
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer.
Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
High Expression of Glucose Transporter 1 on Primary Lesions of Esophageal Squamous Cell Carcinoma is Associated with Hematogenous Recurrence.
Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.
The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Essential Hypertension
Altered erythrocyte membrane protein composition mirrors pleiotropic effects of hypertension susceptibility genes and disease pathogenesis.
Fanconi Syndrome
A Fanconi-Bickel syndrome patient with a novel mutation and accompanying situs inversus totalis.
A novel mutation of the GLUT2 gene in a Turkish patient with Fanconi-Bickel syndrome.
Acute metabolic acidosis in a GLUT2-deficient patient with Fanconi-Bickel syndrome: new pathophysiology insights.
An Indian girl with Fanconi-Bickel syndrome without SLC2A2 gene mutation.
An induced pluripotent stem cell line derived from a patient with neonatal diabetes and Fanconi-Bickel syndrome caused by a homozygous mutation in the SLC2A2 gene.
Elements of diabetic nephropathy in a patient with GLUT 2 deficiency.
Fanconi Bickel syndrome: clinical phenotypes and genetics in a cohort of Sudanese children.
Fanconi Bickel Syndrome: Novel Mutations in GLUT 2 Gene Causing a Distinguished Form of Renal Tubular Acidosis in Two Unrelated Egyptian Families.
Fanconi syndrome and neonatal diabetes: phenotypic heterogeneity in patients with GLUT2 defects.
Fanconi-Bickel Syndrome and Autosomal Recessive Proximal Tubulopathy with Hypercalciuria (ARPTH) Are Allelic Variants Caused by GLUT2 Mutations.
Fanconi-Bickel syndrome as an example of marked allelic heterogeneity.
Fanconi-Bickel syndrome in an infant with cytomegalovirus infection: A case report and review of the literature.
Fanconi-Bickel syndrome in two Palestinian children: marked phenotypic variability with identical mutation.
Fanconi-Bickel syndrome versus osteogenesis imperfeeta: An Iranian case with a novel mutation in glucose transporter 2 gene, and review of literature.
Fanconi-Bickel syndrome--the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature.
Fanconi-Bickel syndrome: GLUT2 mutations associated with a mild phenotype.
Genetic testing of two Pakistani patients affected with rare autosomal recessive Fanconi-Bickel syndrome and identification of a novel SLC2A2 splice site variant.
Hepatocellular Carcinoma in Fanconi-Bickel Syndrome.
Impaired glucose tolerance in Fanconi-Bickel syndrome: Eight patients with two novel mutations.
Mutation analysis of the GLUT2 gene in three unrelated Egyptian families with Fanconi-Bickel syndrome: revisited gene atlas for renumbering.
Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome.
Neonatal diabetes mellitus with hypergalactosemia.
The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function.
The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome.
Two cases of Fanconi-Bickel syndrome: first report from China with novel mutations of SLC2A2 gene.
[Fanconi-Bickel-Syndrom: a novel genetic disease in Original Braunvieh].
Fatty Liver
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice.
Fetal Diseases
Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy.
Fetal Growth Retardation
Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction.
Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation.
Humanin (HN) and glucose transporter 8 (GLUT8) in pregnancies complicated by intrauterine growth restriction.
IFPA 2005 Award in Placentology Lecture. Human placental transport in altered fetal growth: does the placenta function as a nutrient sensor? -- a review.
Insight Into the Pathogenesis of Fetal Growth Restriction in Placental Malaria: Decreased Placental Glucose Transporter Isoform 1 Expression.
Intra-uterine growth restriction differentially regulates perinatal brain and skeletal muscle glucose transporters.
Maternal epidermal growth factor deficiency causes fetal hypoglycemia and intrauterine growth retardation in mice: possible involvement of placental glucose transporter GLUT3 expression.
Maternal Epidermal Growth Factor Deficiency Causes Fetal Hypoglycemia and Intrauterine Growth Retardation in Mice: Possible Involvement of Placental Glucose Transporter GLUT3 Expression1.
Placental and embryonic growth restriction in mice with reduced function epidermal growth factor receptor alleles.
Placental expression of glucose transporter proteins 1 and 3 in growth-restricted fetal rats.
Placental glucose transporter 1 and 3 gene expression in Monochorionic twin pregnancies with selective fetal growth restriction.
Placental glucose transporter 3 (GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction.
Placental transporter activity and expression in relation to fetal growth.
Placental-Specific Overexpression of sFlt-1 Alters Trophoblast Differentiation and Nutrient Transporter Expression in an IUGR Mouse Model.
The effect of intrauterine growth restriction upon fetal and postnatal hepatic glucose transporter and glucokinase proteins.
The relationship between fetal growth restriction and small placenta in 6-mercaptopurine exposed rat.
The transition from fetal growth restriction to accelerated postnatal growth: a potential role for insulin signalling in skeletal muscle.
Fibrosarcoma
Development of diabetes in obese, insulin-resistant mice: essential role of dietary carbohydrate in beta cell destruction.
High-fat diet induced insulin resistance in pregnant rats through pancreatic pax6 signaling pathway.
Insulin-Deficient Mouse ?-Cells Do Not Fully Maturebut Can Be Remedied Through Insulin Replacementby Islet Transplantation.
Pterocarpan-enriched soy leaf extract ameliorates insulin sensitivity and pancreatic ?-cell proliferation in type 2 diabetic mice.
[?-aminobutyric acid fortified rice alleviated oxidative stress and pancreatic injury in type 2 diabetic mice].
Gastrointestinal Neoplasms
Insulin resistance and tissue glycogen content in the tumor-bearing state.
Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle.
Gastrointestinal Stromal Tumors
ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with 18F-FDG PET and Correlation with Genotype and GLUT4 Expression.
Genetic Diseases, Inborn
From splitting GLUT1 deficiency syndromes to overlapping phenotypes.
Glut1 deficiency is a rare but treatable cause of childhood absence epilepsy with atypical features.
Variety of symptoms of GLUT1 deficiency syndrome in three-generation family.
[De Vivo disease. GLUT-1 deficiency syndrome: a case report].
Glioblastoma
Differential expression in glioblastoma multiforme and cerebral hemangioblastoma of cytoplasmic proteins that bind two different domains within the 3'-untranslated region of the human glucose transporter 1 (GLUT1) messenger RNA.
Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.
Distribution of the glucose transporters in human brain tumors.
Expression of facilitative glucose transporter isoforms in human brain tumors.
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.
Prolyl-4-hydroxylase 2 enhances hypoxia-induced glioblastoma cell death by regulating the gene expression of hypoxia-inducible factor-?.
Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood-Brain Barrier of Human Brain and Glioblastoma.
Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.
Glioma
A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.
Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.
Endothelial differentiation in intracerebral and subcutaneous experimental gliomas.
Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia.
Expression of glucose transporter 5 by microglia in human gliomas.
Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors.
Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells.
Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating.
Glucose transporter Glut1 controls diffuse invasion phenotype with perineuronal satellitosis in diffuse glioma microenvironment.
High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium.
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis.
Liposomes actively recognizing the glucose transporter GLUT1 and integrin ?v ?3 for dual-targeting of glioma.
miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
N-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1.
Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment.
Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1?.
Paclitaxel inhibits the migration of CD133+ U251 malignant glioma cells by reducing the expression of glycolytic enzymes.
Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft.
Rat C6 glioma cell growth is related to glucose transport and metabolism.
Specific protein 1 depletion attenuates glucose uptake and proliferation of human glioma cells by regulating GLUT3 expression.
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.
Vascular differentiation and glucose transporter expression in rat gliomas: effects of steroids.
glucan 1,4-alpha-glucosidase deficiency
Effect of acid maltase deficiency on the endosomal/lysosomal system and glucose transporter 4.
Glucose Intolerance
A missense mutation in the CD38 gene, a novel factor for insulin secretion: association with Type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro.
Acute high-fat feeding leads to disruptions in glucose homeostasis and worsens stroke outcome.
Altered expression of glucose transporter isoforms with aging in rats--selective decrease in GluT4 in the fat tissue and skeletal muscle.
Binding forces of hepatic microsomal and plasma membrane proteins in normal and pancreatitic rats: an AFM force spectroscopic study.
Defective insulin-stimulated GLUT4 translocation in brown adipocytes induces systemic glucose homeostasis dysregulation independent of thermogenesis in female mice.
Effect of exercise training on muscle glucose transporter 4 protein and intramuscular lipid content in elderly men with impaired glucose tolerance.
Fermented tea improves glucose intolerance in mice by enhancing translocation of glucose transporter 4 in skeletal muscle.
Functions of pancreatic beta cells and adipocytes in bombesin receptor subtype-3-deficient mice.
Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: enhanced gene expression and synthesis of skeletal muscle glucose transporter 4.
Green and black tea suppress hyperglycemia and insulin resistance by retaining the expression of glucose transporter 4 in muscle of high-fat diet-fed C57BL/6J mice.
High-fat diet affects pregestational adiposity and glucose tolerance perturbing gestational placental macronutrient transporters culminating in an obese offspring in wild-type and glucose transporter isoform 3 heterozygous null mice.
HIV protease inhibitors acutely impair glucose-stimulated insulin release.
Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization.
Maternal nutritional programming of fetal adipose tissue development: long-term consequences for later obesity.
Mechanisms for antidiabetic effect of gingerol in cultured cells and obese diabetic model mice.
MicroRNA?106b regulates skeletal muscle insulin sensitivity and glucose homeostasis by targeting mitofusion?2.
Molecular approach to identify antidiabetic potential of Azadirachta indica.
Muscle GLUT4 in cirrhosis.
Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes.
Porcine adiponectin receptor 1 transgene resists high-fat/sucrose diet-induced weight gain, hepatosteatosis and insulin resistance in mice.
Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice.
Role of chrysin on expression of insulin signaling molecules.
Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.
Thyroid hormones and the potential for regulating glucose metabolism in cardiomyocytes during insulin resistance and T2DM.
Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth.
Glucose Metabolism Disorders
Hepatitis C virus-induced glucose metabolic disorder.
Glycogen Storage Disease
Effect of acid maltase deficiency on the endosomal/lysosomal system and glucose transporter 4.
Hypoglycaemia related to inherited metabolic diseases in adults.
Lactate and its many faces.
[Fanconi-Bickel-Syndrom: a novel genetic disease in Original Braunvieh].
Glycogen Storage Disease Type II
Effect of acid maltase deficiency on the endosomal/lysosomal system and glucose transporter 4.
Glycogen Storage Disease Type IIb
Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.
Glycosuria
Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
Renal injury in Seipin-deficient lipodystrophic mice and its reversal by adipose tissue transplantation or leptin administration alone: adipose tissue-kidney crosstalk.
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria.
Sodium glucose transporter 2 (sglt2) inhibitors: Current status in clinical practice.
Syzygium jambos extract mitigates pancreatic oxidative stress, inflammation and apoptosis and modulates hepatic IRS-2/AKT/GLUT4 signaling pathway in streptozotocin-induced diabetic rats.
Glycosuria, Renal
Pregnancy-Associated Polyuria in Familial Renal Glycosuria.
Gout
Associations between SLC2A9 polymorphisms and gout susceptibility : A meta-analysis.
Correlation of GLUT9 Polymorphisms With Gout Risk.
Uric acid transport and disease.
Granuloma
GLUT-1 in oral benign vascular lesions.
Multifocal congenital pyogenic granuloma successfully treated with oral propranolol.
Head and Neck Neoplasms
Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1? expression, tumor invasiveness, and patient prognosis.
Inhibition of Glucose Transporter 1 (GLUT1) Chemosensitized Head and Neck Cancer Cells to Cisplatin.
Heart Defects, Congenital
Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.
Heart Diseases
Generation of multiple human iPSC lines from peripheral blood mononuclear cells of two SLC2A3 deletion and two SLC2A3 duplication carriers.
Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease?
SGLT2 inhibitors and the changing landscape for treatment of diabetes.
Heart Failure
Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.
Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers.
Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload.
Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy.
New pharmacotherapy for heart failure with reduced ejection fraction.
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition.
Restoration of sarcoplasmic reticulum protein level by thyroid hormone contributes to partial improvement of myocardial function, but not to glucose metabolism in an early failing heart.
Risk stratification tools for heart failure in the diabetes clinic.
The Role of SGLT2 Inhibitor on the Treatment of Diabetic Retinopathy.
[Effects of neregulin on rhesus monkey heart failure induced by rapid pacing]
Hemangioblastoma
Differential expression in glioblastoma multiforme and cerebral hemangioblastoma of cytoplasmic proteins that bind two different domains within the 3'-untranslated region of the human glucose transporter 1 (GLUT1) messenger RNA.
High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium.
Hemangioma
A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.
Benign vascular lesions of the lips: Diagnostic approach.
Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells.
GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms.
GLUT-1 in oral benign vascular lesions.
GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas.
Human monocyte-derived hemangioma-like endothelial cells: evidence from an in vitro study.
Immunoreactivity of Wilms tumor 1 (WT1) as an additional evidence supporting hemangiomatous rather than inflammatory origin in the etiopathogenesis of angiolymphoid hyperplasia with eosinophilia.
Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins.
MRI molecular imaging using GLUT1 antibody-Fe3O4 nanoparticles in the hemangioma animal model for differentiating infantile hemangioma from vascular malformation.
Multifocal congenital pyogenic granuloma successfully treated with oral propranolol.
Segmental congenital hemangiomas: Three cases of a rare entity.
The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children.
Vascular Lesions: GLUT-1 Expression as a Diagnostic Tool to Discriminate Tumors From Malformations.
[Posterior mediastinum infantile hemangioma in an 11 months infant, an unusual finding. A case report and review of the literature].
[Sinusoidal hemangioma: Immunohistochemical analysis with glucose transporter 1 (GLUT1) and williams tumor protein 1 (WT1)]
[The impact of Glut-1 marker application on the diagnosis and treatment of congenital vascular anomalies]
Hemangioma, Capillary
Capillary hemangioma of the central nervous system: a comparative study with lobular capillary hemangioma of the skin.
Glucose transporter isoform-1 receptor-positive infantile capillary hemangiomas: case report and literature review.
Hemiplegia
Lack of SLC2A1 (Glucose Transporter 1) Mutations in 30 Italian Patients With Alternating Hemiplegia of Childhood.
Hepatitis B
Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host.
Hepatolenticular Degeneration
Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Hepatomegaly
Mutation analysis of the GLUT2 gene in three unrelated Egyptian families with Fanconi-Bickel syndrome: revisited gene atlas for renumbering.
Herpes Simplex
A herpes simplex virus vector overexpressing the glucose transporter gene protects the rat dentate gyrus from an antimetabolite toxin.
Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene.
An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid.
Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults.
Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss.
Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke.
Sparing of neuronal function postseizure with gene therapy.
Tumor-specific gene expression using regulatory elements of the glucose transporter isoform 1 gene.
Herpes Zoster
Dysregulation of sonic hedgehog pathway and pericytes in the brain after lentiviral infection.
Protein components of the blood-brain barrier (BBB) in the brainstem area postrema-nucleus tractus solitarius region.
Protein components of the blood-brain barrier (BBB) in the mediobasal hypothalamus.
Histiocytoma
An insulin-like growth factor II-producing histiocytoma associated with hypoglycemia: analysis of the peptide, its gene expression, and glucose transporter isoforms.
HIV Infections
Cerebral glucose transporter expression in HIV infection.
Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression.
Increased uptake and accumulation of vitamin C in human immunodeficiency virus 1-infected hematopoietic cell lines.
Hodgkin Disease
Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
Homocystinuria
[Dietary advice for treatment of inborn errors of metabolism in adult neurology: principes and limitations]
Huntington Disease
Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease.
Glucose transporter isoform expression in Huntington's disease brain.
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
The glucose transporter (GLUT4) enhancer factor is required for normal wing positioning in Drosophila.
Triheptanoin for the treatment of brain energy deficit: A 14-year experience.
[Glucose metabolism in the basal ganglia]
Hyperandrogenism
Decreased brain and muscle ARNT-like protein 1 expression mediated the contribution of hyperandrogenism to insulin resistance in polycystic ovary syndrome.
Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.
Hyperglycemia
13C NMR of intermediary metabolism: implications for systemic physiology.
?-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKK?/NF-?B and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.
A Journey to Understand Glucose Homeostasis: Starting from Rat Glucose Transporter Type 2 Promoter Cloning to Hyperglycemia.
Activation of PERK-eIF2?-ATF4 pathway contributes to diabetic hepatotoxicity: Attenuation of ER stress by Morin.
Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
Antidiabetic and Antihyperlipidemic Properties of a Triterpenoid Compound, Dehydroeburicoic Acid, from Antrodia camphorata in Vitro and in Streptozotocin-Induced Mice.
Antihyperglycemic and antioxidative effects of new herbal formula in streptozotocin-induced diabetic rats.
Antioxidant effect of myricitrin on hyperglycemia-induced oxidative stress in C2C12 cell.
Antioxidant Effects of Oral Ang-(1-7) Restore Insulin Pathway and RAS Components Ameliorating Cardiometabolic Disturbances in Rats.
Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited.
Brain uptake of glucose in diabetes mellitus: the role of glucose transporters.
Changes in Expression of Follicular Glucose Transporters May Be Involved in Ovarian Function Impairment during Diabetic Hyperglycemia.
Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney.
Dapagliflozin: more than just another oral glucose-lowering agent?
Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells.
Downregulation of retinal GLUT1 in diabetes by ubiquitinylation.
Effect of streptozotocin-induced maternal diabetes on fetal rat brain glucose transporters.
Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.
Gene expression of epithelial glucose transporters: the role of diabetes mellitus.
Glucose rapidly decreases plasma membrane GLUT4 content in rat skeletal muscle.
Glucose regulation of glucose transporters in cultured adult and fetal hepatocytes.
Glucose transporter of the blood-brain barrier and brain in chronic hyperglycemia.
Glucose transporter protein responses to selective hyperglycemia or hyperinsulinemia in fetal sheep.
Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy.
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
Glucose transporters: cellular links to hyperglycemia in insulin resistance and diabetes.
Glycemia and exercise training alter glucose transport and GLUT4 in the Zucker rat.
Green and black tea suppress hyperglycemia and insulin resistance by retaining the expression of glucose transporter 4 in muscle of high-fat diet-fed C57BL/6J mice.
Green Tea Ameliorates Hyperglycemia by Promoting the Translocation of Glucose Transporter 4 in the Skeletal Muscle of Diabetic Rodents.
High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice.
Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats.
Hyperglycemia is associated with poor survival in primary central nervous system lymphoma patients.
Hyperglycemia Reduces Mitochondrial Content and Glucose Transporter Expression in Mouse Embryos Developing In Vitro.
Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain.
Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake.
Insulin Mimetic Properties of Extracts Prepared from Bellis perennis.
Intrauterine hyperglycemia increases insulin binding sites but not glucose transporter expression in discrete brain areas in term rat fetuses.
Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ.
Mechanisms of Congenital Malformations in Pregnancies with Pre-existing Diabetes.
Molecular cloning of glucose transporter 1 in grouper Epinephelus coioides and effects of an acute hyperglycemia stress on its expression and glucose tolerance.
N-Hydroxycinnamide Derivatives of Osthole Ameliorate Hyperglycemia through Activation of AMPK and p38 MAPK.
Novel dual-color drug screening model for GLUT4 translocation in adipocytes.
Piperlongumine attenuates oxidative stress, inflammatory, and apoptosis through modulating the GLUT-2/4 and AKT signaling pathway in streptozotocin-induced diabetic rats.
Reactive oxygen species downregulate glucose transport system in retinal endothelial cells.
Red rice koji extract alleviates hyperglycemia by increasing glucose uptake and glucose transporter type 4 levels in skeletal muscle in two diabetic mouse models.
Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats.
Resistance training restores metabolic alterations induced by monosodium glutamate in a sex-dependent manner in male and female rats.
Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy.
Role of liver-type glucose transporter (GLUT2) in transport across the basolateral membrane in rat jejunum.
Short-term mild hyperglycemia enhances insulin-stimulated glucose disposal in lactating goats.
Statin treatment and new-onset diabetes: A review of proposed mechanisms.
Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats.
The cacao procyanidin extract-caused anti-hyperglycemic effect was changed by the administration timings.
The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes.
The glucose transporter 2 undergoes plasma membrane endocytosis and lysosomal degradation in a secretagogue-dependent manner.
The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta.
The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise.
Time-dependent and tissue-specific effects of circulating glucose on fetal ovine glucose transporters.
Time-dependent physiological regulation of ovine placental GLUT-3 glucose transporter protein.
Toona sinensis Roem (Meliaceae) leaf extract alleviates hyperglycemia via altering adipose glucose transporter 4.
Tributyltin in male mice disrupts glucose homeostasis as well as recovery after exposure: mechanism analysis.
Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle.
Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes.
[Effect of glimepiride on the glucose uptake of rat mandibular osteoblasts in hyperglycemia].
[Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus].
Hyperglycinemia, Nonketotic
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Hyperinsulinism
Differential regulation of adipose tissue glucose transporters in genetic obesity (fatty rat). Selective increase in the adipose cell/muscle glucose transporter (GLUT 4) expression.
Glucose transporter protein responses to selective hyperglycemia or hyperinsulinemia in fetal sheep.
GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance.
Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor.
Impact of insulin and glucocorticoid signalling on hepatic glucose homeostasis in the rat exposed to high-fructose diet and chronic stress.
In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissues.
Intrauterine hyperglycemia increases insulin binding sites but not glucose transporter expression in discrete brain areas in term rat fetuses.
Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ.
Putative Involvement of Endocrine Disruptors in the Alzheimer's disease Via the Insulin-Regulated Aminopeptidase / GLUT4 Pathway.
Statin treatment and new-onset diabetes: A review of proposed mechanisms.
Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
Tributyltin in male mice disrupts glucose homeostasis as well as recovery after exposure: mechanism analysis.
Hyperlipidemias
(-)-Epicatechin-3-O-?-D-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice.
Acute hypoxic preconditioning prevents palmitic acid-induced cardiomyocyte apoptosis via switching metabolic GLUT4-glucose pathway back to CD36-fatty acid dependent.
Effects of Bofu-Tsusho-San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice.
Ergostatrien-3?-ol from Antrodia camphorata Inhibits Diabetes and Hyperlipidemia in High-Fat-Diet Treated Mice via Regulation of Hepatic Related Genes, Glucose Transporter 4, and AMP-Activated Protein Kinase Phosphorylation.
Feeding a slowly digestible carbohydrate diet during pregnancy of insulin-resistant rats prevents the excess of adipogenesis in their offspring.
The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise.
Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation.
Hyperparathyroidism
3-Hydroxybutyrate administration elevates plasma parathyroid hormone in a pilot human randomized, controlled, cross over trial.
Hypertension
Analysis of candidate genes for insulin resistance in essential hypertension.
Changes in cardiac energy metabolism during early development of female SHR.
Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension.
Insulin resistance, hypertension and the insulin-responsive glucose transporter, GLUT4.
Role for GLUT1 in diabetic glomerulosclerosis.
Role of GLUT4 on angiotensin 2-induced systemic and renal hemodynamics.
Hypertension, Pulmonary
Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.
Hyperthyroidism
Adenosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart.
Age-related changes in thyroid hormone effects on glucose transporter isoforms of rat heart.
Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray.
IGF-I increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism.
Increased glucose transporter (GLUT4) protein expression in hyperthyroidism.
Quantity of Na/K-ATPase and glucose transporters in the plasma membrane of rat adipocytes is reduced by in vivo triiodothyronine.
Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface.
Thyroid hormone-induced GLUT-1 expression in rat cerebral tissue: effect of age.
Hypertrophy, Left Ventricular
The Effects of Pycnogenol® as Add-on Drug to Metformin Therapy in Diabetic Rats.
Hypoglycemia
An insulin-like growth factor II-producing histiocytoma associated with hypoglycemia: analysis of the peptide, its gene expression, and glucose transporter isoforms.
Brain glucose supply and the syndrome of infantile neuroglycopenia.
Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus.
Changes in muscle mRNAs for hexokinase, phosphofructokinase-1 and glycogen synthase in acute and persistent hypoglycemia induced by tolbutamide in chickens.
Effects of caudal fourth ventricular lactate infusion on hypoglycemia-associated MCT2, GLUT3, GLUT4, GCK, and sulfonylurea receptor-1 gene expression in the ovariectomized female rat LHA and VMH: impact of estradiol.
Glucose deprivation causes posttranscriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization.
Glucose transport in brain and retina: implications in the management and complications of diabetes.
Glucose transporter 2 mediates the hypoglycemia-induced increase in cerebral blood flow.
Glucose transporter gene expression in rat brain: Pretranslational changes associated with chronic insulin-induced hypoglycemia, fasting, and diabetes.
Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia.
Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation.
Glucose transporter proteins in human insulinoma.
Glucose transporters (GLUT1, 2, & 4) in fat, muscle and liver in a rat model of endotoxic shock.
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
Glucose transporters in the human placenta.
Hypoglycemia induced changes in cholinergic receptor expression in the cerebellum of diabetic rats.
Increase in glucose transporter densities of Glut3 and decrease of glucose utilization in rat brain after one week of hypoglycemia.
Insulin-induced hypoglycemia associations with gene expression changes in liver and hypothalamus of chickens from lines selected for low or high body weight.
Low glucose enhances Na+/glucose transport in bovine brain artery endothelial cells.
Maternal epidermal growth factor deficiency causes fetal hypoglycemia and intrauterine growth retardation in mice: possible involvement of placental glucose transporter GLUT3 expression.
Maternal Epidermal Growth Factor Deficiency Causes Fetal Hypoglycemia and Intrauterine Growth Retardation in Mice: Possible Involvement of Placental Glucose Transporter GLUT3 Expression1.
Microarray analysis of PBMC after Plasmodium falciparum infection: Molecular insights into disease pathogenesis.
Quantity of glucose transporter and appetite-associated factor mRNA in various tissues after insulin injection in chickens selected for low or high body weight.
Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes.
Testicular regulation of neuronal glucose and monocarboxylate transporter gene expression profiles in CNS metabolic sensing sites during acute and recurrent insulin-induced hypoglycemia.
The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus.
Time-dependent and tissue-specific effects of circulating glucose on fetal ovine glucose transporters.
Time-dependent physiological regulation of ovine placental GLUT-3 glucose transporter protein.
Toona sinensis Roem (Meliaceae) leaf extract alleviates hyperglycemia via altering adipose glucose transporter 4.
Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia.
Hypopharyngeal Neoplasms
Role of GLUT-1 in the Upregulation of PD-L1 Expression After Radiotherapy and Association of PD-L1 with Favourable Overall Survival in Hypopharyngeal Cancer.
Hypophosphatemia
Fanconi-Bickel Syndrome and Autosomal Recessive Proximal Tubulopathy with Hypercalciuria (ARPTH) Are Allelic Variants Caused by GLUT2 Mutations.
Hypothyroidism
CASE FINDING FOR HYPOTHYROIDISM SHOULD INCLUDE TYPE 2 DIABETES AND METABOLIC SYNDROME PATIENTS: A LATIN AMERICAN THYROID SOCIETY (LATS) POSITION STATEMENT.
Correlation of GLUT1 and GLUT4 with prognosis of patients with hypothyroidism and cardiac insufficiency.
The Possible Mechanisms of the Impaired Insulin Secretion in Hypothyroid Rats.
Thyroid Deficiency Before Birth Alters the Adipose Transcriptome to Promote Overgrowth of White Adipose Tissue and Impair Thermogenic Capacity.
Hypoxia-Ischemia, Brain
Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain.
Circulating blood cellular glucose transporters - Surrogate biomarkers for neonatal hypoxic-ischemic encephalopathy assessed by novel scoring systems.
Rat model of perinatal hypoxic-ischemic brain damage.
Ileitis
Inhibition of autotaxin alleviates inflammation and increases the expression of sodium-dependent glucose cotransporter 1 and Na+/H+ exchanger 3 in SAMP1/Fc mice.
Infarction, Middle Cerebral Artery
Hypoxia-inducible factor 1 contributes to N-acetylcysteine's protection in stroke.
Ischemic injury induces brain glucose transporter gene expression.
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Infections
18F-FDG PET and PET/CT in fever of unknown origin.
A study of the role of glucose transporter 1 (Glut1) in white spot syndrome virus (WSSV) infection.
Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1.
Campylobacter jejuni influences the expression of nutrient transporter genes in the intestine of chickens.
Cellular stress induces a redistribution of the glucose transporter.
Cryptosporidium parvum alters glucose transport mechanisms in infected enterocytes.
Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19.
Enhancement of ATP levels and glucose metabolism during an infection by Chlamydia. NMR studies of living cells.
Glucose transporter GLUT1 influences Plasmodium berghei infection in Anopheles stephensi.
Glucose Transporters and Virulence in Leishmania mexicana.
Glucose uptake and adenoviral mediated GLUT1 infection decrease hypoxia-induced HIF-1alpha levels in cardiac myocytes.
Hepatitis C virus-induced glucose metabolic disorder.
Human cytomegalovirus activates glucose transporter 4 expression to increase glucose uptake during infection.
Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection.
Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression.
Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1.
Immunogold study of regional differences in the distribution of glucose transporter (GLUT-1) in mouse brain associated with physiological and accelerated aging and scrapie infection.
Immunohistochemical Study of Glucose Transporter GLUT-5 in Duodenal Epithelium in Norm and in T-2 Mycotoxicosis.
In Vitro Infection of Trypanosoma cruzi Causes Decrease in Glucose Transporter Protein-1 (GLUT1) Expression in Explants of Human Placental Villi Cultured under Normal and High Glucose Concentrations.
Increased uptake and accumulation of vitamin C in human immunodeficiency virus 1-infected hematopoietic cell lines.
Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain.
Insulin-stimulated translocation of the HepG2/erythrocyte-type glucose transporter expressed in 3T3-L1 adipocytes.
Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization.
Orchestration of the mammalian host cell glucose transporter proteins-1 and 3 by Chlamydia contributes to intracellular growth and infectivity.
Reduction of Mosquito Survival in Mice Vaccinated with Anopheles stephensi Glucose Transporter.
Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.
Systematic genetic dissection of PTS in Vibrio cholerae uncovers a novel glucose transporter and a limited role for PTS during infection of a mammalian host.
The central metabolism regulator EIIAGlc switches Salmonella from growth arrest to acute virulence through activation of virulence factor secretion.
The GhSWEET42 Glucose Transporter Participates in Verticillium dahliae Infection in Cotton.
The N93D mutation of the human T-cell leukemia virus type 1 envelope glycoprotein found in symptomatic patients enhances neuropilin-1 b1 domain binding.
Transport processes of 2-deoxy-D-glucose in erythrocytes infected with Plasmodium yoelii, a rodent malaria parasite.
Vibrio parahaemolyticus infection impaired intestinal barrier function and nutrient absorption in Litopenaeus vannamei.
Inflammatory Bowel Diseases
Glucose transporter expression in the human colon.
Insulin Resistance
?-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKK?/NF-?B and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.
A Chinese Herbal Decoction, Dang Gui Bu Xue Tang, Prepared from Radix Astragali and Radix Angelicae sinensis, Ameliorates Insulin Resistance Induced by A High-Fructose Diet in Rats.
A high fat diet impairs stimulation of glucose transport in muscle. Functional evaluation of potential mechanisms.
A mathematical model and computer simulation study of insulin sensitive glucose transporter regulation.
A mixture of apple pomace and rosemary extract improves fructose consumption-induced insulin resistance in rats: modulation of sarcolemmal CD36 and glucose transporter-4.
A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.
Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction.
Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia.
ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.
Activated central galanin type 1 receptor alleviated insulin resistance in diabetic rat muscle.
Activation of central galanin receptor 2 mitigated insulin resistance in adipocytes of diabetic rats.
Activation of opioid mu-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells.
Activiated galanin receptor 2 attenuates insulin resistance in skeletal muscle of obese mice.
Acute and chronic effects of hyperglycaemia on glucose metabolism.
Adipocyte CREB promotes insulin resistance in obesity.
ADP-ribosylation factor 6 regulates endothelin-1-induced lipolysis in adipocytes.
Age-dependent impairment of adipose-derived stem cells isolated from horses.
Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice.
alpha2 Isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-d-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
Alterations in glucose transporter expression and function in diabetes: mechanisms for insulin resistance.
Altered Central Nutrient Sensing in Male Mice Lacking Insulin Receptors in Glut4-Expressing Neurons.
Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome.
Altered GLUT1 and GLUT3 gene expression and subcellular redistribution of GLUT4: protein in muscle from patients with acanthosis nigricans and severe insulin resistance.
Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter.
An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPAR{gamma}, adipogenesis, and insulin-responsive hexose transport.
Analysis of amino and carboxy terminal GLUT-4 targeting motifs in 3T3-L1 adipocytes using an endosomal ablation technique.
Analysis of candidate genes for insulin resistance in essential hypertension.
Anti-diabetic effects of a coptis chinensis containing new traditional chinese medicine formula in type 2 diabetic rats.
Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus.
Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice.
Antidiabetic effect and mechanism of chitooligosaccharides.
Antidiabetic effect of T-1095, an inhibitor of Na(+)-glucose cotransporter, in neonatally streptozotocin-treated rats.
Antidiabetic Effects of Physical Activity: How It Helps to Control Type 2 Diabetes.
Antioxidant and anti-inflammatory properties of gamma- oryzanol attenuates insulin resistance by increasing GLUT- 4 expression in skeletal muscle of obese animals.
Application of microRNAs in diabetes mellitus.
Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle.
At therapeutic concentrations, olanzapine does not affect basal or insulin-stimulated glucose transport in 3T3-L1 adipocytes.
BAG6 contributes to glucose uptake by supporting the cell surface translocation of the glucose transporter GLUT4.
Beneficial effect of galanin on insulin sensitivity in muscle of type 2 diabetic rats.
Beneficial effects of Aronia melanocarpa berry extract on hepatic insulin resistance in type 2 diabetes mellitus rats.
Biologic activities of naturally occurring human insulin receptor mutations. Evidence that metabolic effects of insulin can be mediated by a kinase-deficient insulin receptor mutant.
Birthweight and fetal glycosylated hemoglobin at birth in newborns carrying the GLUT1 XbaI gene polymorphism.
Bisphenol A and octylphenol exacerbate type 1 diabetes mellitus by disrupting calcium homeostasis in mouse pancreas.
Bisphenol A disrupts glucose transport and neurophysiological role of IR/IRS/AKT/GSK3? axis in the brain of male mice.
Carbenoxolone enhances peripheral insulin sensitivity and GLUT4 expression in skeletal muscle of obese rats: Potential participation of UBC9 protein.
CASE FINDING FOR HYPOTHYROIDISM SHOULD INCLUDE TYPE 2 DIABETES AND METABOLIC SYNDROME PATIENTS: A LATIN AMERICAN THYROID SOCIETY (LATS) POSITION STATEMENT.
Cassia cinnamon for the attenuation of glucose intolerance and insulin resistance resulting from sleep loss.
CELL BIOLOGY SYMPOSIUM: Practical application of the basic aspects of GLUT4 membrane trafficking and insulin signaling on issues related to animal agriculture.
Cellular stress causes accumulation of the glucose transporter at the surface of cells independently of their insulin sensitivity.
Central injection of GALR1 agonist M617 attenuates diabetic rat skeletal muscle insulin resistance through the Akt/AS160/GLUT4 pathway.
Changes in insulin sensitivity in response to different modalities of exercise: a review of the evidence.
Changes in microRNA profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes.
Changes in the gene expression of adiponectin and glucose transporter 12 (GLUT12) in lactating and non-lactating cows
CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function.
Chebulagic acid attenuates HFD/Streptozotocin induced impaired glucose metabolism and insulin resistance via up regulations of PPAR ? and GLUT 4 in type 2 diabetic rats.
Chronic 17beta-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging.
Chronic ethanol feeding impairs AMPK and MEF2 expression and is associated with GLUT4 decrease in rat myocardium.
Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle.
Chronic intermittent hypoxia from pedo-stage decreases glucose transporter 4 expression in adipose tissue and causes insulin resistance.
Combined galanin with insulin improves insulin sensitivity of diabetic rat muscles.
Comparative effects of single-mode vs. duration-matched concurrent exercise training on body composition, low-grade inflammation, and glucose regulation in sedentary, overweight, middle-aged men.
Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
Concentration of Catechins and Caffeine in Black Tea Affects Suppression of Fat Accumulation and Hyperglycemia in High-fat Diet-fed Mice
Conjugated linoleic acid supplementation enhances insulin sensitivity and peroxisome proliferator-activated receptor gamma and glucose transporter type 4 protein expression in the skeletal muscles of rats during endurance exercise.
Cooperative effects of galanin and leptin on alleviation of insulin resistance in adipose tissue of diabetic rats.
Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus.
Critical illness myopathy: what is happening?
Crosstalk between exercise and galanin system alleviates insulin resistance.
Cysteine string protein 1 (CSP1) modulates insulin sensitivity by attenuating glucose transporter 4 (GLUT4) vesicle docking with the plasma membrane.
Decreased brain and muscle ARNT-like protein 1 expression mediated the contribution of hyperandrogenism to insulin resistance in polycystic ovary syndrome.
Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting.
Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients.
Defective insulin-stimulated GLUT4 translocation in brown adipocytes induces systemic glucose homeostasis dysregulation independent of thermogenesis in female mice.
Dehydroepiandrosterone protects against hepatic glycolipid metabolic disorder and insulin resistance induced by high fat via activation of AMPK-PGC-1?-NRF-1 and IRS1-AKT-GLUT2 signaling pathways.
Development of insulin sensitivity in rat skeletal muscle. Studies of glucose transporter and insulin receptor mRNA levels.
Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.
Diabetes Modulates MicroRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p Expression in Muscle: Possible Role in GLUT4 and HK2 Repression.
Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.
Dietary Sea Buckthorn Pomace Induces Beige Adipocyte Formation in Inguinal White Adipose Tissue in Lambs.
Differential Pathways to Adult Metabolic Dysfunction following Poor Nutrition at Two Critical Developmental Periods in Sheep.
Divergent molecular mechanisms for insulin-resistant glucose transport in muscle and adipose cells in vivo.
Effect of ?-sitosterol on glucose homeostasis by sensitization of insulin resistance via enhanced protein expression of PPR? and glucose transporter 4 in high fat diet and streptozotocin-induced diabetic rats.
Effect of a proanthocyanidin-rich extract from longan flower on markers of metabolic syndrome in fructose-fed rats.
Effect of age and caloric restriction on insulin receptor binding and glucose transporter levels in aging rats.
Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity.
Effect of Baicalein on GLUT4 Translocation in Adipocytes of Diet-Induced Obese Mice.
Effect of combination of chlorella intake and aerobic exercise training on glycemic control in type 2 diabetic rats.
Effect of denervation on the expression of two glucose transporter isoforms in rat hindlimb muscle.
Effect of exercise training on skeletal muscle protein expression in relation to insulin sensitivity: Per-protocol analysis of a randomized controlled trial (GO-ACTIWE).
Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats.
Effects of hyperinsulinemia on glucose and lipid transporter expression in insulin-sensitive horses.
Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp.
Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice.
Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle.
Electroacupuncture combined with acarbose improves insulin sensitivity via peroxisome proliferator-activated receptor ? activation and produces a stronger glucose-lowering effect than acarbose alone in a rat model of steroid-induced insulin resistance.
Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men.
Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle.
Evaluation of in vitro/in vivo anti-diabetic effects and identification of compounds from Physalis alkekengi.
Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance.
Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients.
Exercise improved lipid metabolism and insulin sensitivity in rats fed a high-fat diet by regulating glucose transporter 4 (GLUT4) and musclin expression.
Exercise training increases glucose transporter protein GLUT-4 in skeletal muscle of obese Zucker (fa/fa) rats.
Exercise training prevents maturation-induced decrease in insulin sensitivity.
Exercise training prevents skeletal muscle plasma membrane cholesterol accumulation, cortical actin filament loss, and insulin resistance in C57BL/6J mice fed a western-style high-fat diet.
Exercise type and muscle fiber specific induction of caveolin-1 expression for insulin sensitivity of skeletal muscle.
Exercise-induced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats.
Exercise-induced increase in IL-6 level enhances GLUT4 expression and insulin sensitivity in mouse skeletal muscle.
Expansion of the homeostasis model assessment of ?-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2.
Expression of a glucose transporter gene cloned from brain in cellular models of insulin resistance: dexamethasone decreases transporter mRNA in primary cultured adipocytes.
Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors.
Expression of GLUT4 glucose transporter protein in adipose tissue and skeletal muscle from streptozotocin-induced diabetic pregnant rats.
Fibroblast growth factor-1 as a mediator of paracrine effects of canine adipose tissue-derived mesenchymal stem cells on in vitro-induced insulin resistance models.
Fluidity of insulin action.
Four weeks of exercise early in life reprograms adult skeletal muscle insulin resistance caused by a paternal high-fat diet.
From insulin receptor signalling to Glut 4 translocation abnormalities in obesity and insulin resistance.
G-protein coupled receptor 120 is involved in glucose metabolism in fat cells.
Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats.
Galanin participates in the functional regulation of the diabetic heart.
Ganoderma lucidum Extract Reduces Insulin Resistance by Enhancing AMPK Activation in High-Fat Diet-Induced Obese Mice.
Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
Gestational protein restriction impairs insulin-regulated glucose transport mechanisms in gastrocnemius muscles of adult male offspring.
Gliclazide protects 3T3L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation.
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.
Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.
Glucose availability regulates nicotinamide N-methyltransferase expression in adipocytes.
Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: enhanced gene expression and synthesis of skeletal muscle glucose transporter 4.
Glucose transporter isoform-3-null heterozygous mutation causes sexually dimorphic adiposity with insulin resistance.
Glucose transporter protein responses to selective hyperglycemia or hyperinsulinemia in fetal sheep.
Glucose transporter proteins and insulin sensitivity in humans.
GLUT4 and UBC9 protein expression is reduced in muscle from type 2 diabetic patients with severe insulin resistance.
GluT4: A central player in hippocampal memory and brain insulin resistance.
Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).
Green and black tea suppress hyperglycemia and insulin resistance by retaining the expression of glucose transporter 4 in muscle of high-fat diet-fed C57BL/6J mice.
Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet.
Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model.
Hepatitis C virus infection: molecular pathways to metabolic syndrome.
Heterotypic endosomal fusion as an initial trigger for insulin-induced glucose transporter 4 (GLUT4) translocation in skeletal muscle.
High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis.
High-fat diet and leptin treatment alter skeletal muscle insulin-stimulated phosphatidylinositol 3-kinase activity and glucose transport.
Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling.
HIV protease inhibitors acutely impair glucose-stimulated insulin release.
Homology modeling of GLUT4, an insulin regulated facilitated glucose transporter and docking studies with ATP and its inhibitors.
Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes.
Hyperbaric Oxygen Ameliorates Insulin Sensitivity by Increasing GLUT4 Expression in Skeletal Muscle and Stimulating UCP1 in Brown Adipose Tissue in T2DM Mice.
Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats.
Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor.
Hypocretin/orexin modulates body weight and the metabolism of glucose and insulin.
IL-29 promoted obesity-induced inflammation and insulin resistance.
Impact of curcumin treatment on diabetic albino rats.
Impact of flaxseed and soy nuts as dietary supplements on lipid profile, insulin sensitivity, and GLUT4 expression in ovariectomized rats.
Impaired regulation of glucose transporter 4 gene expression in insulin resistance associated with in utero undernutrition.
Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose-fed rats.
Impairment of cardiac insulin signaling in fructose-fed ovariectomized female Wistar rats.
Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats.
Improved insulin sensitivity associated with reduced mitochondrial complex IV assembly and activity.
Increased GLUT-4 translocation mediates enhanced insulin sensitivity of muscle glucose transport after exercise.
Influence of exercise on insulin sensitivity.
Inhibition of cannabinoid CB1 receptor upregulates Slc2a4 expression via nuclear factor-?B and sterol regulatory element-binding protein-1 in adipocytes.
Insulin can enhance GLUT4 gene expression in 3T3-F442A cells and this effect is mimicked by vanadate but counteracted by cAMP and high glucose--potential implications for insulin resistance.
Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.
Insulin resistance and altered glucose transporter 4 expression in experimental uremia.
Insulin resistance and glucose transporter expression during the euglycemic hyperinsulinemic clamp in the lamb.
Insulin resistance and GLUT-4 glucose transporter in adipocytes from hypertensive rats.
Insulin resistance and muscle insulin receptor substrate-1 serine hyperphosphorylation.
Insulin resistance in adult cardiomyocytes undergoing dedifferentiation: role of GLUT4 expression and translocation.
Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle.
Insulin resistance in fat cells from obese Zucker rats--evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4.
Insulin resistance in HIV infection: drugs, host responses, or restoration to health?
Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation.
Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle.
Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart.
Insulin resistance, hypertension and the insulin-responsive glucose transporter, GLUT4.
Insulin resistance: the consequence of a neuroendocrine disturbance?
Insulin sensitivity in cystic fibrosis.
Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects.
Intact glucose transport in morphologically altered denervated skeletal muscle from quadriplegic patients.
Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.
Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ.
Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats.
Lifelong Physical Activity Prevents Aging-Associated Insulin Resistance in Human Skeletal Muscle Myotubes via Increased Glucose Transporter Expression.
Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM.
Lipid induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling.
Low cytochrome oxidase 4I1 links mitochondrial dysfunction to obesity and type 2 diabetes in humans and mice.
Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis.
Maternal nutritional programming of fetal adipose tissue development: long-term consequences for later obesity.
Maternal periodontitis decreases plasma membrane GLUT4 content in skeletal muscle of adult offspring.
Maternal protein restriction in rats leads to reduced PGC-1? expression via altered DNA methylation in skeletal muscle.
Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione.
Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review.
Metabolic and therapeutic lessons from genetic manipulation of GLUT4.
Metabolic syndrome and insulin resistance: perioperative considerations.
Metabolically healthy obese vs. Metabolic syndrome - The crosslink between nutritional exposure to bisphenols and physical exercise.
Metabolism and acetylation contribute to leucine-mediated inhibition of cardiac glucose uptake.
MicroRNA-17 impairs glucose metabolism in insulin-resistant skeletal muscle via repressing glucose transporter 4 expression.
MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus.
Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol.
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.
Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.
Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle.
Muscle group-specific regulation of GLUT 4 glucose transporters in control, diabetic, and insulin-treated diabetic rats.
Muscle insulin resistance amended with exercise training: role of GLUT4 expression.
Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors.
Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes.
Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes.
Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK.
Naringenin Promotes Thermogenic Gene Expression in Human White Adipose Tissue.
Normal insulin receptor tyrosine kinase activity and glucose transporter (GLUT 4) levels in the skeletal muscle of hyperinsulinaemic hypertensive rats.
Nutraceutical effects of fucoxanthin for obesity and diabetes therapy: a review.
Ontology of the apelinergic system in mouse pancreas during pregnancy and relationship with ?-cell mass.
OS 15-09 DOES ACE2-ANGIOTENSIN-(1-7) AXIS PROTECT FROM AGING-ASSOCIATED LOSS OF SKELETAL MUSCLE FUNCTION?
Overexpression of Insulin Degrading Enzyme could Greatly Contribute to Insulin Down-regulation Induced by Short-Term Swimming Exercise.
Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in post-infarct heart failure.
Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review.
Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.
Peripheral insulin resistance in ILK-depleted mice by reduction of GLUT4 expression.
PI3K-GLUT4 Signal Pathway Associated with Effects of EX-B3 Electroacupuncture on Hyperglycemia and Insulin Resistance of T2DM Rats.
Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes.
Placental restriction reduces insulin sensitivity and expression of insulin signaling and glucose transporter genes in skeletal muscle, but not liver, in young sheep.
Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of non-insulin-dependent diabetes mellitus.
Polyphenols activate energy sensing network in insulin resistant models.
Pomegranate: a fruit that ameliorates metabolic syndrome.
Postreceptor defect in insulin action in streptozotocin-induced diabetic rats.
Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus.
Prolactin activation of the long form of its cognate receptor causes increased visceral fat and obesity in males as shown in transgenic mice expressing only this receptor subtype.
Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: Involvement of the adaptive antioxidant response.
Protein restriction during gestation alters histone modifications at the glucose transporter 4 (GLUT4) promoter region and induces GLUT4 expression in skeletal muscle of female rat offspring.
Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review.
Pterocarpan-enriched soy leaf extract ameliorates insulin sensitivity and pancreatic ?-cell proliferation in type 2 diabetic mice.
Rac-1 superactivation triggers insulin-independent glucose transporter 4 (GLUT4) translocation that bypasses signaling defects exerted by c-Jun N-terminal kinase (JNK)- and ceramide-induced insulin resistance.
Randomized clinical trial to compare the effects of preoperative oral carbohydrate versus placebo on insulin resistance after colorectal surgery.
Rapamycin impairs HPD-induced beneficial effects on glucose homeostasis.
Reduced expression of collagen VI alpha 3 (COL6A3) confers resistance to inflammation-induced MCP1 expression in adipocytes.
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition.
Reduced Insulin Resistance Contributes to the Beneficial Effect of Protein Tyrosine Phosphatase-1B Deletion in a Mouse Model of Sepsis.
Reduced Slc2a4/GLUT4 expression in subcutaneous adipose tissue of monosodium glutamate obese mice is recovered after atorvastatin treatment.
Repeated prolonged whole-body low-intensity exercise: effects on insulin sensitivity and limb muscle adaptations.
Resistance training enhances components of the insulin signaling cascade in normal and high-fat-fed rodent skeletal muscle.
Resistance training is medicine: effects of strength training on health.
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice.
Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone.
Role of Magnesium in Type 2 Diabetes Mellitus.
Role of retinol-binding protein 4 in the pathogenesis of Type 2 diabetes.
Rosiglitazone balances insulin-induced exo- and endocytosis in single 3T3-L1 adipocytes.
Route of nutrient delivery affects insulin sensitivity and liver glucose transporter expression in rat.
Sco2 deficient mice develop increased adiposity and insulin resistance.
Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.
Serum amyloid A attenuates cellular insulin sensitivity by increasing JNK activity in 3T3-L1 adipocytes.
Sexually Dimorphic Diet-Induced Insulin Resistance in Obese Tissue Inhibitor of Metalloproteinase-2 (TIMP-2)-Deficient Mice.
SNARE Proteins Underpin Insulin-Regulated GLUT4 Traffic.
Sodium glucose transporter 2 (sglt2) inhibitors: Current status in clinical practice.
SPARC is over-expressed in adipose tissues of diet-induced obese rats and causes insulin resistance in 3T3-L1 adipocytes.
Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells.
Subcellular distribution and phosphorylation state of insulin receptors from insulin- and isoproterenol-treated rat adipose cells.
Subetta Enhances Sensitivity of Human Muscle Cells to Insulin.
Supplementation of pyruvate prevents palmitate-induced impairment of glucose uptake in C2 myotubes.
Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects.
Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.
The actin-related p41ARC subunit contributes to p21-activated kinase-1 (PAK1)-mediated glucose uptake into skeletal muscle cells.
The anti-diabetic effect of anthocyanins in streptozotocin-induced diabetic rats through glucose transporter 4 regulation and prevention of insulin resistance and pancreatic apoptosis.
The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat diet.
The effect of BPA exposure on insulin resistance and type 2 diabetes - The impact of muscle contraction.
The effect of electric field, magnetic field, and infrared ray combination to reduce HOMA-IR index and GLUT 4 in diabetic model of Mus musculus.
The effect of exercise on epigenetic modifications of PGC1: The impact on type 2 diabetes.
The effect of exercise on skeletal muscle glucose uptake in type 2 diabetes: An epigenetic perspective.
THE EFFECT OF SALBUTAMOL ON PGC-1 ? AND GLUT4 mRNA EXPRESSION IN THE LIVER AND MUSCLE OF ELDERLY DIABETIC MICE.
The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome.
The genetics and pathophysiology of type II and gestational diabetes.
The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function.
The influence of diet and physical activity on insulin sensitivity.
The Interacting Domains of PREP1 and p160 are Endowed with a Remarkable Structural Stability.
The lipid phosphatase SHIP2 controls insulin sensitivity.
The neuropeptide galanin benefits insulin sensitivity in subjects with type 2 diabetes.
The polygenetically inherited metabolic syndrome of WOKW rats is associated with insulin resistance and altered gene expression in adipose tissue.
Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes.
TNF-? promotes insulin resistance in obstructive sleep apnea-hypopnea syndrome.
Trigonelline and vildagliptin antidiabetic effect: improvement of insulin signalling pathway.
Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell.
Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes.
Use of GLUT-4 null mice to study skeletal muscle glucose uptake.
Usefulness of combining intermittent hypoxia and physical exercise in the treatment of obesity.
[Influence of modified qianjin huanglian pill on pancreas of mice with insulin resistance]
[Insulin resistance and glucose transporter]
[Overview on hypoglycemic active constituents of traditional Chinese medicine based on insulin receptor signaling pathway].
[Progress in the role of oxidative stress in the pathogenesis of type 2 diabetes].
[Resistive training reduces inflammation in skeletal muscle and improves the peripheral insulin sensitivity in obese rats induced by hyperlipidic diet].
[Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma)]
Insulinoma
Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells.
Effects of sodium butyrate on glucose transporter and glucose-phosphorylating enzyme gene expression in RINm5F insulinoma cells.
Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes.
Glucose transporter proteins in human insulinoma.
GLUT2 surface expression and intracellular transport via the constitutive pathway in pancreatic beta cells and insulinoma: evidence for a block in trans-Golgi network exit by brefeldin A.
Insulin secretion, insulin content and glucose phosphorylation in RINm5F insulinoma cells after transfection with human GLUT2 glucose-transporter cDNA.
Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic ?-cells.
STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells.
Intellectual Disability
Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency.
Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy.
Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency.
Study of paediatric patients with the clinical and biochemical phenotype of glucose transporter type 1 deficiency syndrome.
Symptomatic West Syndrome Secondary to Glucose Transporter-1(GLUT1) Deficiency with Complete Response to 4:1 Ketogenic Diet.
Intracranial Aneurysm
Association between semicarbazide-sensitive amine oxidase, a regulator of the glucose transporter, and elastic lamellae thinning during experimental cerebral aneurysm development: laboratory investigation.
Ischemic Stroke
2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-?-D-pyranoside confers neuroprotection in cell and animal models of ischemic stroke through calpain1/PKA/CREB-mediated induction of neuronal glucose transporter 3.
Cerebral glucose transporter: The possible therapeutic target for ischemic stroke.
Involvement of glucose transporter overexpression in the protection or damage after ischemic stroke.
Keratosis
Fluorodeoxyglucose uptake positive-seborrheic keratosis on positron emission tomography may result from high expression of glucose transporter.
Ketosis
Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.
Sodium glucose transporter 2 inhibition, euglycemic ketosis and bone mineral loss: Refining clinical practices.
Kidney Neoplasms
Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer.
[Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof]
Lafora Disease
Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review.
Lesch-Nyhan Syndrome
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Leukemia
Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1.
Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells.
GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1.
Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1.
Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain.
Inhibition of glucose transporter gene expression by antisense nucleic acids in HL-60 leukemia cells.
Leukemia, Myeloid, Acute
Downregulation of GLUT3 Promotes Apoptosis and Chemosensitivity of Acute Myeloid Leukemia Cells via EGFR Signaling.
Leukemia, T-Cell
Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1.
Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures.
Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.
GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1.
Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1.
Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain.
The N93D mutation of the human T-cell leukemia virus type 1 envelope glycoprotein found in symptomatic patients enhances neuropilin-1 b1 domain binding.
Leukocytosis
Physiological leukocytosis during pregnancy is associated with changes in glucose transporter expression of maternal peripheral blood granulocytes and monocytes.
Leukoencephalopathies
Leukoencephalopathy in infancy with glucose transporter type 1 deficiency syndrome.
Lichen Planus, Oral
Hypoxia-inducible factor-1? and glucose transporter 1 in the malignant transformation of oral lichen planus.
Lipoma
Cellular and molecular features of lipoma tissue: comparison with normal adipose tissue.
Liver Cirrhosis
Muscle GLUT4 in cirrhosis.
Liver Diseases
Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.
Liver Diseases, Alcoholic
Alterations in glucose transporter proteins in alcoholic liver disease in the rat.
Liver Failure, Acute
Selectively increased expression of the astrocytic/endothelial glucose transporter protein GLUT1 in acute liver failure.
Liver Neoplasms
In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter.
Lung Neoplasms
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Circular RNA MYLK Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer Cells by Sponging miR-195-5p and Increasing Glucose Transporter Member 3 Expression.
Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.
Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer.
Correlation of Glut-1 glucose transporter expression with.
Deficient glucose uptake is linked to impaired Glut1 expression upon CD3/CD28 stimulation in memory T cells from pleural effusions secondary to lung cancer.
Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases.
Differentiation of histological subtypes in lung cancer with 18F-FDG-PET 3-point imaging and kinetic analysis.
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Expression and clinical significance of glucose transporter 1 mRNA in bronchial brushing liquid-based cytology specimens from patients with and without lung cancer.
Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin ?1/Src/FAK Signaling.
Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection.
Glucose transporter expression in developing fetal lungs and lung neoplasms.
Glucose-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer.
GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer.
High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-d-glucose uptake.
Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells.
Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress.
KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition.
Lung but not brain cancer cell malignancy inhibited by commonly used anesthetic propofol during surgery: Implication of reducing cancer recurrence risk.
Lung squamous cell carcinoma exhibits a targetable glucose dependency unique among non-small cell lung cancers.
MUC1 Expression in Pulmonary Metastatic Tumors: A Comparison of Primary Lung Cancer.
Nonimmobilized Biomaterial Capillary Electrophoresis for Screening Drugs Targeting Human Glucose Transporter 1.
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells.
Predictive factors in radiotherapy for non-small cell lung cancer: present status.
Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Prognostic significance of genetic variants in GLUT1 in stage III non-small cell lung cancer treated with radiotherapy.
Protein kinase C-iota-mediated glycolysis promotes non-small-cell lung cancer progression.
Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Relationship between (18)F-FDG uptake on PET and various biologic molecular markers in benign pulmonary lesion: comparison with primary lung cancer.
Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer.
Sodium/iodide symporter expression in primary lung cancer and comparison with glucose transporter 1 expression.
The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
Tumor cell-derived angiopoietin-like protein 2 establishes a preference for glycolytic metabolism in lung cancer cells.
Unusual False-Positive Mesenteric Lymph Nodes Detected by PET/CT in a Metastatic Survey of Lung Cancer.
[Expression of GLUT1 protein and its relationship with uptake of FDG in non-small cell lung cancer tissues.]
Lymphatic Metastasis
Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype.
Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis.
Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma.
The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery.
Lymphoma
18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential.
Correlation between positron emission tomography findings and glucose transporter 1, 3 and L-type amino acid transporter 1 mRNA expression in primary central nervous system lymphomas.
Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma.
Effect of Letrozole, a selective aromatase inhibitor, on testicular activities in adult mice: Both in vivo and in vitro study.
Expression of hypoxia-inducible factor 1?, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors.
Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?
LncRNA GASL1 inhibits growth and promotes expression of apoptosis-associated proteins in prostate carcinoma cells through GLUT-1.
Lysophosphatidic acid promotes survival of T lymphoma cells by altering apoptosis and glucose metabolism.
Lymphoma, B-Cell
Betaine ameliorates impaired steroidogenesis and apoptosis in mice granulosa cells induced by high glucose concentration.
Comparison of specific expression profile in two in vitro hypoxia models.
Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways.
Depression mediates impaired glucose tolerance and cognitive dysfunction: A neuromodulatory role of rosiglitazone.
Diagnostic Roles of Immunohistochemistry in Thymic Tumors: Differentiation between Thymic Carcinoma and Thymoma.
Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
LncRNA GASL1 inhibits growth and promotes expression of apoptosis-associated proteins in prostate carcinoma cells through GLUT-1.
Lymphoma, Large B-Cell, Diffuse
Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Lysosomal Storage Diseases
Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Malabsorption Syndromes
Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats.
The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function.
Malaria
A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters.
Insight Into the Pathogenesis of Fetal Growth Restriction in Placental Malaria: Decreased Placental Glucose Transporter Isoform 1 Expression.
Microarray analysis of PBMC after Plasmodium falciparum infection: Molecular insights into disease pathogenesis.
Orthosteric-allosteric dual inhibitors of PfHT1 as selective antimalarial agents.
Reduction of Mosquito Survival in Mice Vaccinated with Anopheles stephensi Glucose Transporter.
Malnutrition
Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice.
Adaptations of glucose metabolism during pregnancy and lactation.
Differential Pathways to Adult Metabolic Dysfunction following Poor Nutrition at Two Critical Developmental Periods in Sheep.
Effects of chronic undernutrition on glucose uptake and glucose transporter proteins in rat heart.
Impaired regulation of glucose transporter 4 gene expression in insulin resistance associated with in utero undernutrition.
Maternal undernutrition during late gestation-induced intrauterine growth restriction in the rat is associated with impaired placental GLUT3 expression, but does not correlate with endogenous corticosterone levels.
Pre- and early-postnatal nutrition modify gene and protein expressions of muscle energy metabolism markers and phospholipid Fatty Acid composition in a muscle type specific manner in sheep.
Up-regulation of phosphatidylinositol 3-kinase and glucose transporter 4 in muscle of rats subjected to maternal undernutrition.
Melanoma
4'-Bromo-resveratrol, a dual Sirtuin-1 and Sirtuin-3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming.
Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
Characterization of glycolysis-related gene expression in malignant melanoma.
Diagnostic and Prognostic Value of Glucose Transporters in Melanocytic Lesions.
Diagnostic and Prognostic Value of ProEx C and GLUT1 in Melanocytic Lesions.
Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity.
Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions.
Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells.
LncRNA DBH-AS1 facilitates the tumorigenesis of melanoma by targeting miR-233-3p via IGF-1R/Akt signaling.
Variability in glucose transporter-1 levels and hexokinase activity in human melanoma.
MELAS Syndrome
Alternating hemiplegia of childhood: metabolic studies in the largest European series of patients.
Meningioma
Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.
Expression of GLUT3 and HIF-1? in Meningiomas of Various Grades Correlated with Peritumoral Brain Edema.
Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
Immunohistochemical Detection of CD34, E-cadherin, Claudin-1, Glucose Transporter 1, Laminin, and Protein Gene Product 9.5 in 28 Canine and 8 Feline Meningiomas.
Meningitis
Escherichia coli K1 Modulates Peroxisome Proliferator-Activated Receptor ? and Glucose Transporter 1 at the Blood-Brain Barrier in Neonatal Meningitis.
Meningomyelocele
Association of facilitated glucose transporter 2 gene variants with the myelomeningocele phenotype.
Genetic variations in the GLUT3 gene associated with myelomeningocele.
Menkes Kinky Hair Syndrome
A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport.
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Mesothelioma
Diagnostic mesothelioma biomarkers in effusion cytology.
Immunohistochemical differentiation of reactive from malignant mesothelium as a diagnostic aid in canine pericardial disease.
Practical utility of insulin-like growth factor II mRNA-binding protein 3, glucose transporter 1, and epithelial membrane antigen for distinguishing malignant mesotheliomas from benign mesothelial proliferations.
Mesothelioma, Malignant
Diagnostic value of GLUT-1 in distinguishing malignant mesothelioma from reactive mesothelial cells: a meta-analysis.
Practical utility of insulin-like growth factor II mRNA-binding protein 3, glucose transporter 1, and epithelial membrane antigen for distinguishing malignant mesotheliomas from benign mesothelial proliferations.
Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids.
Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.
[Expression of glucose transporter protein 1 and desmin in reactive mesothelial hyperplasia and epithelioid malignant mesothelioma].
Metabolic Diseases
Effects of genetics and in utero diet on murine pancreatic development.
MiRNA-21 Reverses High Glucose and High Insulin Induced Insulin Resistance in 3T3-L1 Adipocytes through Targeting Phosphatase and Tensin Homologue.
Metabolic Syndrome
Aerobic exercise training induces metabolic benefits in rats with metabolic syndrome independent of dietary changes.
CASE FINDING FOR HYPOTHYROIDISM SHOULD INCLUDE TYPE 2 DIABETES AND METABOLIC SYNDROME PATIENTS: A LATIN AMERICAN THYROID SOCIETY (LATS) POSITION STATEMENT.
Decreased glucose transporter protein (GLUT4) in skeletal muscle of hypertriglyceridaemic insulin-resistant rat.
Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice.
Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model.
Insulin resistance and muscle insulin receptor substrate-1 serine hyperphosphorylation.
Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis.
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.
Positron emission tomography probe demonstrates a striking concentration of ribose salvage in the liver.
Metabolism, Inborn Errors
Fanconi-Bickel syndrome--a congenital defect of the liver-type facilitative glucose transporter. SSIEM Award. Society for the Study of Inborn Errors of Metabolism.
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
methylenetetrahydrofolate dehydrogenase (nad+) deficiency
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Microcephaly
Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
Allelic variations of glut-1 deficiency syndrome: the chinese experience.
Atypical Manifestations in Glut1 Deficiency Syndrome.
Childhood chorea with cerebral hypotrophy: a treatable GLUT1 energy failure syndrome.
Derivative chromosome 1 and GLUT1 deficiency syndrome in a sibling pair.
First report of glucose transporter 1 deficiency syndrome in Korea with a novel splice site mutation.
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Functional studies of the T295M mutation causing Glut1 deficiency: glucose efflux preferentially affected by T295M.
Glucose Transporter Type 1 Deficiency Syndrome: Developmental Delay and Early-Onset Ataxia in a Novel Mutation of the SLC2A1 Gene.
Glucose transporter type 1 deficiency: Ketogenic diet in three patients with atypical phenotype.
GLUT-1 deficiency presenting with seizures and reversible leukoencephalopathy on MRI imaging.
Glut1 deficiency syndrome: Absence epilepsy and La Soupe du Jour.
Imaging the metabolic footprint of Glut1 deficiency on the brain.
Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome.
SLC2A1 gene analysis of Japanese patients with glucose transporter 1 deficiency syndrome.
The Many Faces of Glut1 Deficiency Syndrome.
[Type 1 glucose transporter (Glut1) deficiency: manifestations of a hereditary neurological syndrome]
Migraine Disorders
Glucose transporter 1 deficiency syndrome and hemiplegic migraines as a dominant presenting clinical feature.
Mitochondrial Diseases
Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review.
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Motor Neuron Disease
Evaluation of glucose tolerance and intestinal luminal membrane glucose transporter function in horses with equine motor neuron disease.
Mouth Neoplasms
Elevated Sad1 and UNC84 Domain Containing 2 (SUN2) level inhibits cell growth and aerobic glycolysis in oral cancer through reducing the expressions of glucose transporter 1 (GLUT1) and lactate dehydrogenase A (LDHA).
Vital staining with iodine solution in oral cancer: iodine infiltration, cell proliferation, and glucose transporter 1.
Movement Disorders
Allelic variations of glut-1 deficiency syndrome: the chinese experience.
Childhood chorea with cerebral hypotrophy: a treatable GLUT1 energy failure syndrome.
Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases.
Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy.
Glucose transporter type 1 deficiency due to SLC2A1 gene mutations--a rare but treatable cause of metabolic epilepsy and extrapyramidal movement disorder; own experience and literature review.
NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges.
SLC2A1 gene analysis of Japanese patients with glucose transporter 1 deficiency syndrome.
Study of paediatric patients with the clinical and biochemical phenotype of glucose transporter type 1 deficiency syndrome.
The face of Glut1-DS patients: A 3D Craniofacial Morphometric Analysis.
The Many Faces of Glut1 Deficiency Syndrome.
[Glucose transporter 1 deficiency syndrome: features of movement disorders, diagnosis and treatment].
Multiple Myeloma
Glucose metabolism as a target of histone deacetylase inhibitors.
Inhibition of glucose transporter 1 induces apoptosis and sensitizes multiple myeloma cells to conventional chemotherapeutic agents.
Multiple Sclerosis
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Muscular Diseases
Critical illness myopathy: what is happening?
Myocardial Infarction
Aerobic training prior to myocardial infarction increases cardiac GLUT4 and partially preserves heart function in spontaneously hypertensive rats.
Myocardial Ischemia
Increased sarcolemmal glucose transporter abundance in myocardial ischemia.
Persistent myocardial ischemia increases GLUT1 glucose transporter expression in both ischemic and non-ischemic heart regions.
Post-ischemic stimulation of 2-deoxyglucose uptake in rat myocardium: role of translocation of Glut-4.
Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis.
sDR5-Fc inhibits macrophage M1 polarization by blocking the glycolysis.
Myocardial Stunning
Enhancement of glucose uptake in stunned myocardium: role of glucose transporter.
Myoclonic Epilepsies, Progressive
Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.
Myoclonus
Glucose Transporter 1 Deficiency: A Treatable Cause of Opsoclonus and Epileptic Myoclonus.
The benefits of a Neurogenetics clinic in an adult Academic Teaching Hospital.
Nasopharyngeal Carcinoma
Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-?B Signaling Pathways.
Necrobiosis Lipoidica
Expression of the human erythrocyte glucose transporter Glut-1 in areas of sclerotic collagen in necrobiosis lipoidica.
Neoplasm Metastasis
18F-fluoromisonidazole positron emission tomography may be applicable in the evaluation of colorectal cancer liver metastasis.
A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.
Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.
Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer.
Characterization of glycolysis-related gene expression in malignant melanoma.
Collapsing the Metabolic PON2zi Scheme in Pancreatic Ductal Adenocarcinoma.
Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway.
Deregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric Cancer.
Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases.
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
GLUT1 participates in tamoxifen resistance in breast cancer cells through autophagy regulation.
Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.
Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype.
HMGA1 Promotes Hepatic Metastasis of Colorectal Cancer by Inducing Expression of Glucose Transporter 3 (GLUT3).
Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis.
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
Prognostic significance of hypoxia-inducible factor-1? expression in advanced pharyngeal cancer without human papillomavirus infection.
Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma.
Quantitative protein expression of blood-brain barrier transporters in the vasculature of brain metastases of patients with lung and breast cancer.
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma.
The glucose transporter and blood-brain barrier of human brain tumors.
The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery.
Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.
Tris-base buffer: a promising new inhibitor for cancer progression and metastasis.
Vascular expression of glucose transporter in and around hematogenous metastases of the human brain. Immunohistochemical observations.
Neoplasms
(18)F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer.
(18)F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma.
(18)F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: A clinicopathological study.
(18)FDG PET for grading malignancy in thymic epithelial tumors: Significant differences in (18)FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: Preliminary study.
18-Carbon polyunsaturated fatty acids ameliorate palmitate-induced inflammation and insulin resistance in mouse C2C12 myotubes.
18F-FDG PET and PET/CT in fever of unknown origin.
18F-FDG PET/CT Evaluation of Thymomas: a Pictorial Review.
18F-FDG uptake in well-differentiated neuroendocrine tumors correlates with both Ki-67 and VHL pathway inactivation.
18F-FDG uptake on PET could be a?predictive marker of Excision Repair Cross-Complementation Group 1 (ERCC1) expression in patients with thoracic neoplasms?
18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
18F-FES and 18F-FDG PET for Differential Diagnosis and Quantitative Evaluation of Mesenchymal Uterine Tumors: Correlation with Immunohistochemical Analysis.
18F-fluorodeoxyglucose uptake in tumor.
18F-HX4/18F-FMISO-based micro PET for imaging of tumor hypoxia and radiotherapy-associated changes in mice.
2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma.
4-Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF-? and regulating the expression of insulin signal transduction proteins.
?-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons.
A Nonsense Mitochondrial DNA Mutation Associates with Dysfunction of HIF1? in a Von Hippel-Lindau Renal Oncocytoma.
A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer.
A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.
A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.
A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.
A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism.
A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.
A tumor-associated glycosylation change in the glucose transporter GLUT1 controlled by tumor suppressor function in human cell hybrids.
Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1?, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.
Abnormal facilitative glucose transporter gene expression in human islet cell tumors.
ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with 18F-FDG PET and Correlation with Genotype and GLUT4 Expression.
Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
Adaptation to HIF1? Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism.
Adenine Nucleotide Translocase 2 as an Enzyme Related to [18F] FDG Accumulation in Various Cancers.
Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
Ameliorative effect of fermentable fibres on adiposity and insulin resistance in C57BL/6 mice fed a high-fat and sucrose diet.
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development.
Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma.
Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review.
Anti-breast Cancer Enhancement of a Polysaccharide From Spore of Ganoderma lucidum With Paclitaxel: Suppression on Tumor Metabolism With Gut Microbiota Reshaping.
Anti-Hyperglycemic Effect of Fermented Ginseng in Type 2 Diabetes Mellitus Mouse Model.
Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice.
Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice.
Anticancer agents interacting with membrane glucose transporters.
Antimetabolic Effects of Polyphenols in Breast Cancer Cells: Focus on Glucose Uptake and Metabolism.
Antitumor effects of energy restriction-mimetic agents: thiazolidinediones.
Antitumor effects of WNT2B silencing in GLUT1 overexpressing cisplatin resistant head and neck squamous cell carcinoma.
Anti PD-1 treatment increases [18F]FDG uptake by cancer cells in a mouse B16F10 melanoma model.
Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway.
Applicability of 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia.
Association between 18F-fluorodeoxyglucose-PET/CT and histological grade of uterine endometrial carcinoma.
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Betaine ameliorates impaired steroidogenesis and apoptosis in mice granulosa cells induced by high glucose concentration.
Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species.
Bioactive compounds in plant materials for the prevention of diabetesand obesity.
Biologic correlates of (18)F-FDG uptake on PET in pulmonary pleomorphic carcinoma.
Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.
Biological characterisation of breast cancer by means of PET.
Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.
Breast cancer proteomics reveals correlation between Estrogen Receptor status and differential phosphorylation of PGRMC1.
Cancer cell spheroids are a better screen for the photodynamic efficiency of glycosylated photosensitizers.
Cancer Cells' Metabolism Dynamics in Renal Cell Carcinoma Patients' Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186.
Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells.
Carpesium abrotanoides (L.) Root as a Potential Source of Natural Anticancer Compounds: Targeting Glucose Metabolism and PKM2/HIF-1? Axis of Breast Cancer Cells.
CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.
Cell Microenvironment-Controlled Antitumor Drug Releasing-Nanomicelles for GLUT1-Targeting Hepatocellular Carcinoma Therapy.
Cellular and molecular characterization of a feline insulinoma.
Cellular and molecular features of lipoma tissue: comparison with normal adipose tissue.
Characterization of a near-infrared fluorescent DCPO-tagged glucose analogue for cancer cell imaging.
Chromosomal assignment of seven genes on canine chromosomes by fluorescence in situ hybridization.
Circular RNAs Regulate Glucose Metabolism in Cancer Cells.
Clinical Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography in Superficial Esophageal Squamous Cell Carcinoma.
Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹?F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Clinicopathological significance of glucose transporter protein-1 overexpression in human osteosarcoma.
Co-treatment with nitroglycerin and metformin exhibits physicochemically and pathohistologically detectable anticancer effects on fibrosarcoma in hamsters.
Coexpression of glucose transporter 1 and matrix metalloproteinase-2 in human cancers.
Combination of Palmitic Acid and Methylseleninic Acid Induces Mitochondria-Dependent Apoptosis via Attenuation of the IRE1? Arm and Enhancement of CHOP in Hepatoma.
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth.
Comparative effects of single-mode vs. duration-matched concurrent exercise training on body composition, low-grade inflammation, and glucose regulation in sedentary, overweight, middle-aged men.
Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts.
Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer.
Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.
Comparison of near-infrared fluorescent deoxyglucose probes with different dyes for tumor diagnosis in vivo.
Conformational Studies of Glucose Transporter 1 (GLUT1) as an Anticancer Drug Target.
Conjugated linoleic acids reduce body fat in healthy postmenopausal women.
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Construction of a GLUT-1 and HIF-1? gene knockout cell model in HEp-2 cells using the CRISPR/Cas9 technique.
Correlation and expression analysis of hypoxia-inducible factor 1?, glucose transporter 1 and lactate dehydrogenase 5 in human gastric cancer.
Correlation between biological marker expression and F-fluorodeoxyglucose uptake in cervical cancer measured by positron emission tomography.
Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma.
Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas.
Correlation between maximum standardized uptake values on FDG-PET and microenvironmental factors in patients with clinical stage IA radiologic pure-solid lung adenocarcinoma.
Correlation Between von Hippel-Lindau Gene Expression and Tumor SUVmax and Survival Prognosis in Hepatocellular Carcinoma.
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.
Correspondence re: Ito T, Noguchi Y, Satoh S, Hayashi H, Inayama Y, Kitamura H: Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Mod Pathol 1998; 11:437-443.
Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report.
Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway.
Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice.
Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors.
Deregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric Cancer.
Design of antitumor agents containing carbohydrate based on GLUT1, and evaluation of antiproliferative activity.
Design, Synthesis, and Evaluation of GLUT Inhibitors.
Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method.
Diacylglycerol kinase ? predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma.
Diagnostic potential of hypoxia-induced genes in liquid biopsies of breast cancer patients.
Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material.
Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway.
Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation.
Distinct glycolytic pathway regulation in liver, tumour and skeletal muscle of mice with cancer cachexia.
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
Down-Regulation of Hypoxia-Inducible Factor-1? and Downstream Glucose Transporter Protein-1 Gene by ?-elemene Enhancing the Radiosensitivity of Lung Adenocarcinoma Transplanted Tumor.
Downregulating hypoxia-inducible factor 1 alpha augments transcatheter arterial embolization to treat hepatocellular carcinomas in rats.
Downregulation of GLUT3 Promotes Apoptosis and Chemosensitivity of Acute Myeloid Leukemia Cells via EGFR Signaling.
Effect of gemcitabine on the uptake of (18)F-fluorodeoxyglucose and (18)F-fluorothymidine in lung adenocarcinoma A549 cells and the animal tumor model.
Effect of Glucose on GLUT1-Dependent Intracellular Ascorbate Accumulation and Viability of Thyroid Cancer Cells.
Effect of Lactobacillus fermentum TKSN041 on improving streptozotocin-induced type 2 diabetes in rats.
Effect on the Expression of MMP-2, MT-MMP in Laryngeal Carcinoma Hep-2 Cell Line by Antisense Glucose Transporter-1.
Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes.
Effects of Nigella sativa seed polysaccharides on type 2 diabetic mice and gut microbiota.
Effects of unilateral nasal obstruction on the characteristics of jaw-closing muscles in growing rats.
Efficacy of Positron Emission Tomography in distinguishing brain tumours from inflammation.
EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors.
Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Endothelial cell implantation and survival within experimental gliomas.
Energy metabolism in glioblastoma stem cells: PPAR? a metabolic adaptor to intratumoral microenvironment.
Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
Enhanced Antitumor Efficacy by d-Glucosamine-Functionalized and Paclitaxel-Loaded Poly(Ethylene Glycol)-Co-Poly(Trimethylene Carbonate) Polymer Nanoparticles.
Enhanced expression of glucose transporter GLUT3 in tumorigenic HeLa cell hybrids associated with tumor suppressor dysfunction.
Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming.
Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool.
Eugenol attenuates inflammatory response and enhances barrier function during lipopolysaccharide-induced inflammation in the porcine intestinal epithelial cells.
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme.
Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Evaluation of type 2 diabetic mellitus animal models via interactions between insulin and mitogen?activated protein kinase signaling pathways induced by a high fat and sugar diet and streptozotocin.
Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans.
Ex vivo responsiveness of head and neck squamous cell carcinoma to glufosfamide, a novel alkylating agent.
Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.
Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma.
Expression of 4F2hc (CD98) in pulmonary neuroendocrine tumors.
Expression of facilitative glucose transporter isoforms in human brain tumors.
Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.
Expression of facilitative glucose transporters in gastric tumors.
Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II.
Expression of glucose transporter isoforms (GLUT1, GLUT2) and activities of hexokinase, pyruvate kinase, and malic enzyme in preneoplastic and neoplastic rat renal basophilic cell lesions.
Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
Expression of glucose transporter protein-1 (Glut-1) in ocular surface squamous neoplasia.
Expression of glucose transporters in head-and-neck tumors.
Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary.
Expression of GLUT1 in primary renal tumors: morphologic and biologic implications.
Expression of hypoxia inducible factor 1{alpha} in thyroid carcinomas.
Expression of Monocarboxylate Transporter 1 Is Associated With Better Prognosis and Reduced Nodal Metastasis in Pancreatic Ductal Adenocarcinoma.
Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia.
Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.
Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
Expression of the plasma membrane markers aquaporin 1 (AQP1), glucose transporter 1 (GLUT1) and Na, K-ATPase in canine mammary glands and mammary tumours.
Extracellular gating of glucose transport through GLUT 1.
Extranodal Nasal NK/T-Cell Lymphoma: A Rare Oral Presentation and FASN, CD44 and GLUT-1 Expression.
Facilitative glucose transporter expression in human cancer tissue.
FDG accumulation and tumor biology.
FDG PET imaging of Ela1-myc mice reveals major biological differences between pancreatic acinar and ductal tumours.
FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading.
Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.
Fructose 1,6-Bisphosphatase 1 Expression Reduces 18F-FDG Uptake in Clear Cell Renal Cell Carcinoma.
Gastric Schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: Report of two cases.
Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1? expression, tumor invasiveness, and patient prognosis.
Gene expression of tumour necrosis factor and insulin signalling-related factors in subcutaneous adipose tissue during the dry period and in early lactation in dairy cows.
Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer.
Genes are differentially expressed in the epididymal fat of rats rendered obese by a high-fat diet.
Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members, obese and non-obese controls - a preliminary report.
Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells.
Glucose as a prognostic factor in ovarian carcinoma.
Glucose conjugation for the specific targeting and treatment of cancer.
Glucose Metabolism Measured by [F]Fluorodeoxyglucose Positron Emission Tomography Is Independent of PTEN/AKT Status in Human Colon Carcinoma Cells.
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
Glucose transport and apoptosis after gene therapy with HSV thymidine kinase.
Glucose transporter 1 (GLUT1) and its emerging role as a significant prognostic marker in systemic malignancies.
Glucose transporter 1 expression in canine osteosarcoma.
Glucose Transporter 1 Expression in Odontogenic Keratocyst, Dentigerous Cyst, and Ameloblastoma: An Immunohistochemical Study.
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin ?1/Src/FAK Signaling.
Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: A useful diagnostic tool for malignant pleural effusions.
Glucose transporter 1-mediated vascular translocation of nanomedicines enhances accumulation and efficacy in solid tumors.
Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells.
Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating.
Glucose transporter expression of an esophageal gastrointestinal tumor detected by F-18 FDG PET/CT.
Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays.
Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis.
Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation.
Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
Glucose transporter isotypes switch in T-antigen-transformed pancreatic beta cells growing in culture and in mice.
Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy.
Glucose transporter protein 1-targeted RNA interference inhibits growth and invasion of the osteosarcoma cell line MG63 in vitro.
Glucose transporter protein-independent tumor cell accumulation of fluorine-18-AFDG, a lipophilic fluorine-18-FDG analog.
Glucose transporter proteins in human insulinoma.
Glucose Transporter Regulation in Cancer: A Profile and the Loops.
Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors.
Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis.
Glucose Uptake and Intracellular pH in a Mouse Model of Ductal Carcinoma In situ (DCIS) Suggests Metabolic Heterogeneity.
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.
Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cells.
Glucose-installed biodegradable polymeric micelles for cancer-targeted drug delivery system: synthesis, characterization and in vitro evaluation.
Glucose-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer.
Glucosylated polyethylenimine as a tumor-targeting gene carrier.
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.
Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.
Glut-1 Expression Correlates with Basal-like Breast Cancer.
GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms.
Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
GLUT-1 staining of squamous cell carcinomas of the uterine cervix identifies a novel element of invasion.
GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.
GLUT1 expression in human papillomavirus-positive anogenital lesions.
GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker.
Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy.
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions.
GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma.
Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells.
GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
GLUT1-mediated effective anti-miRNA21 pompon for cancer therapy.
GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates.
GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer.
Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer.
Glycolysis inhibition as a strategy for hepatocellular carcinoma treatment?
Glycolysis-related protein expression in thyroid cancer.
Growth condition-dependent synchronized changes in transcript levels of type II hexokinase and type 1 glucose transporter in tumor cells.
H2A Monoubiquitination Links Glucose Availability to Epigenetic Regulation of the Endoplasmic Reticulum Stress Response and Cancer Cell Death.
HDAC Inhibition Decreases the Expression of EGFR in Colorectal Cancer Cells.
Hemolytic E. coli promotes colonic tumorigenesis in females.
Hepatoprotective Effects of Polydatin-Loaded Chitosan Nanoparticles in Diabetic Rats: Modulation of Glucose Metabolism, Oxidative Stress, and Inflammation Biomarkers.
Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria.
HIF-1alpha Modulates Energy Metabolism in Cancer Cells by Inducing Over-expression of Specific Glycolytic Isoforms.
HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.
HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas.
High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-d-glucose uptake.
High Expression of Glucose Transporter 1 on Primary Lesions of Esophageal Squamous Cell Carcinoma is Associated with Hematogenous Recurrence.
High Expression of Solute Carrier Family 2 Member 1 (SLC2A1) in Cancer Cells Is an Independent Unfavorable Prognostic Factor in Pediatric Malignant Peripheral Nerve Sheath Tumor.
High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium.
High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer.
Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype.
Hyperglycemia promotes K-Ras-induced lung tumorigenesis through BASCs amplification.
Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
Hypoxia Imaging and Biological Evaluation of the Radiosensitizing Effect of Oleanolic Acid.
Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis.
Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts.
Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas.
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876.
Identification of a novel proliferation-dependent C-rich element that mediates inhibition of the rat GLUT1 promoter.
Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth.
Identification of insulin-like growth factor (IGF) and glucose transporter-1 and -3 mRNA in CNS tumors.
IL4 receptor ? mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
Immunhistochemical expression of GLUT1 is associated with low grade and low stage of urinary bladder cancer.
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas.
Immunohistochemical detection of tumour hypoxia.
Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma.
Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes.
Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors.
Immunohistochemical investigation of metabolic markers fatty acid synthase (FASN) and glucose transporter 1 (GLUT1) in normal endometrium, endometrial hyperplasia, and endometrial malignancy.
Immunohistochemical localization of glucose transporter 1 and 3 in the scrotal and abdominal testes of a dog.
Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia.
Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
Impact of GLUT1 and Ki-67 expression on early?stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.
In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy.
In vivo imaging of hypoxia-inducible factor regulation in a subcutaneous and orthotopic GL261 glioma tumor model using a reporter gene assay.
In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay.
Inactivation of O(6)-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors.
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma.
Increases in mRNA levels of glucose transporters types 1 and 3 in Ehrlich ascites tumor cells during tumor development.
Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells.
Infectious Knockdown of CREB and HIF-1 for the Treatment of Metastatic Uveal Melanoma.
Inhibiting cancer metabolism by aromatic carbohydrate amphiphiles that act as antagonists of the glucose transporter GLUT1.
Inhibition of Glucose Transporter 1 (GLUT1) Chemosensitized Head and Neck Cancer Cells to Cisplatin.
Inhibition of glucose transporter gene expression by antisense nucleic acids in HL-60 leukemia cells.
Inhibition of glucose uptake and suppression of glucose transporter 1 mRNA expression in L929 cells by tumour necrosis factor-alpha.
Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress.
Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.
Inhibition of Non-flux-Controlling Enzymes Deters Cancer Glycolysis by Accumulation of Regulatory Metabolites of Controlling Steps.
INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
Insulin receptor substrate-2 regulates aerobic glycolysis in mouse mammary tumor cells via glucose transporter 1.
Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle.
Insulin resistance in HIV-related lipodystrophy.
Insulinoma associated with a case of multiple endocrine neoplasia type I: Functional somatostatin receptors and abnormal glucose-induced insulin secretion.
Interactions of a Water-Soluble Glycofullerene with Glucose Transporter 1. Analysis of the Cellular Effects on a Pancreatic Tumor Model.
Interleukin-17A Differentially Induces Inflammatory and Metabolic Gene Expression in the Adipose Tissues of Lean and Obese Mice.
Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Investigation of Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas: A Study Associated With a National Survey of Solid Pseudopapillary Neoplasms.
Iodine-125 interstitial brachytherapy reduces tumor growth via Warburg effect inhibition in non-small cell lung cancer A549 ×enografts.
Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1? signaling pathway.
KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition.
Kinetics of transport and phosphorylation of glucose in cancer cells.
Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate.
L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma.
Lactate dehydrogenase A inhibition by small molecular entities: steps in the right direction.
LAT-1 and GLUT-1 Carrier Expression and Its Prognostic Value in Gastroenteropancreatic Neuroendocrine Tumors.
Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
LINC01638 lncRNA promotes cancer cell proliferation in hepatocellular carcinoma by increasing cancer cell glucose uptake.
LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
Long non-coding RNA HAND2-AS1 targets glucose metabolism and inhibits cancer cell proliferation in osteosarcoma.
Long non-coding RNA-NEF targets glucose transportation to inhibit the proliferation of non-small-cell lung cancer cells.
Low-dose testosterone alleviates vascular damage caused by castration in male rats in puberty via modulation of the PI3K/AKT signaling pathway.
Low-grade malignant soft-tissue perineurioma: interphase fluorescence in situ hybridization.
Lung Cancer: A Comparative Study of Metabolism Related Protein Expression in Cancer Cells and Tumor Associated Stroma.
Mannose-conjugated platinum complexes reveals effective tumor targeting mediated by glucose transporter 1.
Maternal periodontitis decreases plasma membrane GLUT4 content in skeletal muscle of adult offspring.
Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer.
Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice.
Metabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis.
Metabolic control analysis indicates a change of strategy in the treatment of cancer.
Metabolic control of glucose degradation in yeast and tumor cells.
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.
Metabolic vulnerabilities in endometrial cancer.
Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1+ Cells.
Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism.
MicroRNA Expression Profile Reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer.
miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.
Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In Vivo.
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.
Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy.
Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
Molecular Pathogenesis of Cholangiocarcinoma.
Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.
Monitoring the mechanism of anti-cancer agents to inhibit colorectal cancer cell proliferation: Enzymatic biosensing of glucose combined with molecular docking.
Monosaccharide Analogues of Anticancer Peptide R-Lycosin-I: Role of Monosaccharide Conjugation in Complexation and the Potential of Lung Cancer Targeting and Therapy.
MUC1 Expression in Pulmonary Metastatic Tumors: A Comparison of Primary Lung Cancer.
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.
Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.
Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer.
Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK.
Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
Neuroimaging of juvenile pilocytic astrocytomas: an enigma.
NF?B up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
Noncompetitive blocking of human GLUT1 hexose transporter by methylxanthines reveals an exofacial regulatory binding site.
Nonimmobilized Biomaterial Capillary Electrophoresis for Screening Drugs Targeting Human Glucose Transporter 1.
Novel predictive biomarkers for cervical cancer prognosis.
Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways.
Nutritional and physiological consequences of tumour glycolysis.
O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms.
Oncocytic Adrenocortical Carcinoma With Low 18F-FDG Uptake and the Absence of Glucose Transporter 1 Expression.
Oncoprotein LAMTOR5 Activates GLUT1 Via Upregulating NF-?B in Liver Cancer.
One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy.
Operable Non-Small Cell Lung Cancer: Correlation of Volumetric Helical Dynamic Contrast-enhanced CT Parameters with Immunohistochemical Markers of Tumor Hypoxia.
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Over-expression of facilitative glucose transporter genes in human cancer.
Over-expression of glucose transporter isoform GLUT1 and hexokinase I in rat renal oncocytic tubules and oncocytomas.
Overcoming Multidrug Resistance through the GLUT1-Mediated and Enzyme-Triggered Mitochondrial Targeting Conjugate with Redox-Sensitive Paclitaxel Release.
Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors.
Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.
Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
Overexpression of METTL3 associated with the metabolic status on 18F-FDG PET/CT in patients with Esophageal Carcinoma.
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells.
Oxygen metabolism in oral cancer: HIF and GLUTs (Review).
p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
Pacinian collagenoma: A distinct form of sclerotic fibroma.
Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.
PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
PD-L1 in Lung Adenocarcinoma: Insights into the Role of 18F-FDG PET/CT.
Performance of a 99mTc-labelled 1-thio-beta-D-glucose 2,3,4,6-tetra-acetate analogue in the detection of infections and tumours in mice: a comparison with [18F]FDG.
Photothermally triggered cytosolic drug delivery of glucose functionalized polydopamine nanoparticles in response to tumor microenvironment for the GLUT1-targeting chemo-phototherapy.
Physicochemical and pathohistological changes in experimental fibrosarcoma tumors of hamsters treated with metformin and itraconazole.
Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.
Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas.
Potent anti-proliferative actions of a non-diuretic glucosamine derivative of ethacrynic acid.
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer.
Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer.
Prediction of Treatment Outcomes in Patients with Chest Wall Sarcoma: Evaluation with PET/CT.
Predictive factors in radiotherapy for non-small cell lung cancer: present status.
Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Prevalence of FoxP3(+) Cells in Canine Tumours and Lymph Nodes Correlates Positively with Glucose Transporter 1 Expression.
Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
Prognostic impacts of hypoxic markers in soft tissue sarcoma.
Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
Prognostic Significance of 18F-FDG PET/CT Metabolic Parameters and Tumor Galectin-1 Expression in Patients With Surgically Resected Lung Adenocarcinoma.
Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma.
Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies.
Prognostic value of GLUT-1 expression in ovarian surface epithelial tumors: a morphometric study.
Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis.
Protective effect of aqueous seed extract of Vitis Vinifera against oxidative stress, inflammation and apoptosis in the pancreas of adult male rats with diabetes mellitus.
Protein binding regions of the mRNAs for the 55 kDa tumor necrosis factor receptor and the glucose transporter 1: sequence homology and competition for cellular proteins.
Proteome analysis of hypoxic glioblastoma cells reveals sequential metabolic adaptation  of one-carbon metabolic pathways.
Putative Mechanisms Responsible for the Antihyperglycemic Action of Lactobacillus paracasei HII01 in Experimental Type 2 Diabetic Rats.
Quantitative determinations of the steady state transcript levels of hexokinase isozymes and glucose transporter isoforms in normal rat tissues and the malignant tumor cell line AH130.
Quercetin suppresses insulin receptor signaling through inhibition of the insulin ligand-receptor binding and therefore impairs cancer cell proliferation.
Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy.
Regulation of glucose transporter protein-1 and vascular endothelial growth factor by hypoxia inducible factor 1? under hypoxic conditions in Hep-2 human cells.
Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75.
Regulation of the Warburg effect in early-passage breast cancer cells.
Regulatory effect of chemerin and therapeutic efficacy of chemerin?9 in pancreatogenic diabetes mellitus.
Relations of TGF-beta1 with HIF-1alpha, GLUT-1 and longer survival of colorectal cancer patients.
Relationship between (18)F-FDG uptake on PET and various biologic molecular markers in benign pulmonary lesion: comparison with primary lung cancer.
Relationship between (18)F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma.
Relationship Between Tumor Immune Markers and Fluorine-18-?-Methyltyrosine ([18F]FAMT) Uptake in Patients with Lung Cancer.
Relationship of polychlorinated biphenyls with type 2 diabetes and hypertension.
Restoration of adipose function in obese, glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein ? upregulation.
Role of glucose metabolism related gene GLUT1 in the occurrence and prognosis of colorectal cancer.
Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
ROS-Switchable Polymeric Nanoplatform with Stimuli-Responsive Release for Active Targeted Drug Delivery to Breast Cancer.
Salicylketoximes That Target Glucose Transporter?1 Restrict Energy Supply to Lung Cancer Cells.
Sclerosing perineurioma: a clinicopathological study of five cases and diagnostic utility of immunohistochemical staining for GLUT1.
Sclerosing perineurioma: tumor of the hand with a short T2.
Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases.
Segmental congenital hemangiomas: Three cases of a rare entity.
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer.
Significance of GLUT1 expression in adenocarcinoma and adenoma of the ampulla of Vater.
Significant coexpression of GLUT-1, Bcl-xL, and Bax in colorectal cancer.
Silencing of Glucose Transporter Protein-1 by RNA Interference Inhibits Human Osteosarcoma Mg63 Cells Growth in vivo.
Silencing of Glut1 induces chemoresistance via modulation of Akt/GSK-3?/?-catenin/survivin signaling pathway in breast cancer cells.
Similar PAI-1 expression in visceral and subcutaneous fat of postmenopausal women.
Sirtuin 6 and metabolic genes interplay in Warburg effect in cancers.
Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy.
Solid tumours arising from differently pre-oxygenated cells: comparable growth rates despite dissimilar tissue oxygenation.
Statins impair glucose uptake in tumor cells.
Steady state transcript levels of the type II hexokinase and type 1 glucose transporter in human tumor cell lines.
Strategy for identification of novel glucose transporter family members by using internet-based genomic databases.
Sublethal exposures of diazinon alters glucose homostasis in Wistar rats: Biochemical and molecular evidences of oxidative stress in adipose tissues.
Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth.
Sustain, Adapt, and Overcome-Hypoxia Associated Changes in the Progression of Lymphatic Neoplasia.
Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Targeted cancer therapy with a 2-deoxyglucose-based adriamycin complex.
Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation.
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.
Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-d-g1ucose modified SPIOs.
Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma.
Targeting HIF2? translation with Tempol in VHL-deficient clear cell renal cell carcinoma.
Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.
Targeting uptake transporters for cancer imaging and treatment.
The "don't eat me" signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma.
The angiogenic switch leads to a metabolic shift in human glioblastoma.
The blood-brain and gut-vascular barriers: from the perspective of claudins.
The BRAF V600E Mutation in Papillary Thyroid Carcinomas Is Associated with Glucose Transporter 1 Overexpression.
The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression.
The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
The Effect of Carbogen Breathing on 18F-FDG Uptake in Non-Small-Cell Lung Cancer.
The effect of PPAR-gamma agonist on 18F-FDG uptake in tumor and macrophages and tumor cells.
The effects of fish oil on gene expression in patients with polycystic ovary syndrome.
The erythrocyte-type glucose transporter in blood vessels of primary and metastatic brain tumors.
The glucose transporter and blood-brain barrier of human brain tumors.
The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas.
The growth factor-like effects of tumor necrosis factor-alpha. Stimulation of glucose transport activity and induction of glucose transporter and immediate early gene expression in 3T3-L1 preadipocytes.
The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro.
The Medicinal Chemistry of Theragnostics, Multimodality Imaging and Applications of Nanotechnology in Cancer.
The NADPH Oxidase Nox4 mediates tumour angiogenesis.
The NF-?B signalling pathway regulates GLUT6 expression in endometrial cancer.
The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients.
The progress and development of GLUT1 inhibitors targeting cancer energy metabolism.
The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery.
The role of PET in localization of neuroendocrine and adrenocortical tumors.
The Sustainability of Energy Conversion Inhibition for Tumor Ferroptosis Therapy and Chemotherapy.
The Tilapia collagen peptide mixture TY001 protects against LPS-induced inflammation, disruption of glucose metabolism, and aberrant expression of circadian clock genes in mice.
The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake.
The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.
The XbaI G>T polymorphism of the glucose transporter 1 gene modulates 18F-FDG uptake and tumor aggressiveness in breast cancer.
Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma.
Thymol improves barrier function and attenuates inflammatory responses in porcine intestinal epithelial cells during lipopolysaccharide (LPS)-induced inflammation.
Thymoquinone ameliorates obesity-induced metabolic dysfunction, improves reproductive efficiency exhibiting a dose-organ relationship.
Trigonelline reduced diabetic nephropathy and insulin resistance in type 2 diabetic rats through peroxisome proliferator-activated receptor-?.
Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells.
Tumor necrosis factor alpha-induced glucose transporter (GLUT-1) mRNA stabilization in 3T3-L1 preadipocytes. Regulation by the adenosine-uridine binding factor.
Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes.
Tumor necrosis factor-alpha regulation of glucose transporter (GLUT1) mRNA turnover. Contribution of the 3'-untranslated region of the GLUT1 message.
Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction.
Tumor perfusion using first-pass F-18 FDG PET images.
Tumor stiffness measured by shear wave elastography correlates with tumor hypoxia as well as histologic biomarkers in breast cancer.
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Up-regulation of Key Glycolysis Proteins in Cancer Development.
UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma.
Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.
Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data.
Usefulness of automatic quantification of immunochemical staining on whole tumor sections for correlation with oncological small animal pet studies: an example with cell proliferation, glucose transporter 1 and FDG.
Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer.
Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
Variability in glucose transporter-1 levels and hexokinase activity in human melanoma.
Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression.
Vitamin C supplementation had no side effect in non-cancer, but had anticancer properties in ovarian cancer cells.
Vitexin, an inhibitor of hypoxia-inducible factor-1?, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma.
von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase.
Vulnerability of Left Amygdala to Total Sleep Deprivation and Reversed Circadian Rhythm in Molecular Level: Glut1 as a Metabolic Biomarker.
Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.
Xanthine oxidase inhibitory activity and antihyperuricemic effect of Moringa oleifera Lam. leaf hydrolysate rich in phenolics and peptides.
Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3.
Zinc oxide nanoparticles augment CD4, CD8, and GLUT-4 expression and restrict inflammation response in streptozotocin-induced diabetic rats.
[Effects of early insulin therapy on nuclear factor kappaB pathway in skeletal muscle of diabetes: experiment with rats]
[Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors]
[Expression of glucose transporter 1 in human breast carcinoma and its clinical significance]
[Inhibiting the expression of glucose transporter 1 reduces the proliferation, invasion and migration of neuroblastoma cells].
[New functional imaging technique "positron emission tomography"]
[Preparation and characterization of tumor targeted CdTe quantum dots modified with functional polymer].
[Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells].
[Sinusoidal hemangioma: Immunohistochemical analysis with glucose transporter 1 (GLUT1) and williams tumor protein 1 (WT1)]
[The preventive effect of total saponins of Panax japonicus on nonsteroidal anti-inflammatory drug-induced enteropathy].
[Value of 18F-FDG metabolic imaging in diagnosis and treatment of head and neck tumors and its mechanism study]
Neoplasms, Squamous Cell
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Nephrolithiasis
Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients.
Nerve Sheath Neoplasms
Claudin-1 and Glucose Transporter 1 Immunolabelling in a Canine Intraneural Perineurioma.
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
Sclerosing perineurioma: a clinicopathological study of five cases and diagnostic utility of immunohistochemical staining for GLUT1.
Nervous System Diseases
Atypical Manifestations in Glut1 Deficiency Syndrome.
First report of GLUT1 deficiency syndrome in Chinese patients with novel and hot spot mutations in SLC2A1 gene.
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.
Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective.
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes.
The Effects of Ketogenic Diet on Seizures, Cognitive Functions, and Other Neurological Disorders in Classical Phenotype of Glucose Transporter 1 Deficiency Syndrome.
Neural Tube Defects
Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy.
Glucose transporter gene expression in rat conceptus during high glucose culture.
Neurilemmoma
Glucose Transporter 3 and 1 may Facilitate High Uptake of 18F-FDG in Gastric Schwannoma.
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Neuroblastoma
Akt and cAMP response element binding protein mediate 17?-estradiol regulation of glucose transporter 3 expression in human SH-SY5Y neuroblastoma cell line.
Fluoxetine induces glucose uptake and modifies glucose transporter palmitoylation in human peripheral blood mononuclear cells.
Glucose transporter GLUT8 translocation in neurons is not insulin responsive.
Influence of glucose transporter 1 activity inhibition on neuroblastoma in vitro.
Nucleoside 5'-phosphorothioate derivatives are highly effective neuroprotectants.
[Inhibiting the expression of glucose transporter 1 reduces the proliferation, invasion and migration of neuroblastoma cells].
Neurodegenerative Diseases
In vivo assessment of lipid peroxidation products associated with age-related neurodegenerative diseases.
Near-critical GLUT1 and Neurodegeneration.
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Triheptanoin for the treatment of brain energy deficit: A 14-year experience.
Neuroendocrine Tumors
Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
Expression of glucose transporter-1 is correlated with hypoxia-inducible factor 1? and malignant potential in pancreatic neuroendocrine tumors.
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation.
Implications of fluorodeoxyglucose uptake in low-intermediate grade metastatic neuroendocrine tumors from peptide receptor radionuclide therapy outcome viewpoint: A semi-quantitative standardized uptake value-based analysis.
Neurofibroma
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Neurofibrosarcoma
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Neuroinflammatory Diseases
HIF-1? stabilization reduces retinal degeneration in a mouse model of retinitis pigmentosa.
PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity.
Neurologic Manifestations
Novel insight into GLUT1 Deficiency Syndrome: screening for emotional and behavioral problems in youths following ketogenic diet.
Phenotypic variability of GLUT1 deficiency: When is necessary to suspect?
The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes.
Neuroma
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Neuronal Ceroid-Lipofuscinoses
Clinical Application of Targeted Next-Generation Sequencing Panels and Whole Exome Sequencing in Childhood Epilepsy.
Metabolic epilepsies: approaches to a diagnostic challenge.
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Nevus
Diagnostic and Prognostic Value of Glucose Transporters in Melanocytic Lesions.
Nevus, Pigmented
Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions.
Niemann-Pick Disease, Type C
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Niemann-Pick Diseases
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Non-alcoholic Fatty Liver Disease
Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.
Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.
Hepatic steatosis in type 1 diabetes.
[Effects of pentoxifylline on hepatic nuclear factor-kappa B signaling pathway and insulin resistance in nonalcoholic steatohepatitis rats induced by fat-rich diet]
Obesity
?-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons.
?-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKK?/NF-?B and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.
A mathematical model and computer simulation study of insulin sensitive glucose transporter regulation.
Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue.
Adipose Tissue, Inter-Organ Communication, and the Path to Type 2 Diabetes: The 2016 Banting Medal for Scientific Achievement Lecture.
Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.
Alterations in glucose transporter expression and function in diabetes: mechanisms for insulin resistance.
Analysis of the HepG2/erythrocyte glucose transporter locus in a family with type 2 (non-insulin-dependent) diabetes and obesity.
Analysis of three glucose transporter genes in a Caucasian population: no associations with non-insulin-dependent diabetes and obesity.
Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat.
Changes in Renal Glucose Transporters in an Animal Model of Metabolic Syndrome.
Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue.
Differential regulation of adipose tissue glucose transporters in genetic obesity (fatty rat). Selective increase in the adipose cell/muscle glucose transporter (GLUT 4) expression.
Downregulation of mouse intestinal Na(+)-coupled glucose transporter SGLT1 by gum arabic (Acacia Senegal).
Effect of aging and obesity on insulin responsiveness and glut-4 glucose transporter content in skeletal muscle of Fischer 344 x Brown Norway rats.
Effects of okadaic acid, an inhibitor of protein phosphatases-1 and -2A, on glucose transport and metabolism in skeletal muscle.
Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha.
Fluidity of insulin action.
Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members, obese and non-obese controls - a preliminary report.
Gestational 30% and 40% fat diets increase brain GLUT2 and neuropeptide Y immunoreactivity in neonatal Wistar rats.
Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice.
GLUT4 expression in human muscle fibres is not correlated with intracellular triglyceride (TG) content. Is TG a maker or a marker of insulin resistance?
High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis.
Insulin and glucose transporter gene expression in obesity and diabetes.
Liver and muscle-fat type glucose transporter gene expression in obese and diabetic rats.
MiRNA-21 Reverses High Glucose and High Insulin Induced Insulin Resistance in 3T3-L1 Adipocytes through Targeting Phosphatase and Tensin Homologue.
Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes.
Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
Polymorphisms in stearoyl coa desaturase and sterol regulatory element binding protein interact with N-3 polyunsaturated fatty acid intake to modify associations with anthropometric variables and metabolic phenotypes in Yup'ik people.
Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
Quantitative immunogold study of glucose transporter (GLUT-1) in five brain regions of scrapie-infected mice showing obesity and reduced glucose tolerance.
Relationships of PPARgamma and PPARgamma2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys.
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Structure and mechanism of the mammalian fructose transporter GLUT5.
Suppression of GLUT4 expression in skeletal muscle of rats that are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity.
The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise.
Trangenic and knockout rodents: novel insights into mechanisms of body weight regulation.
[Progress of researches on mechanisms of acupuncture therapy for insulin resistance].
[Relationships of glucose transporter 4 with cognitive changes induced by high fat diet and glucose metabolism in hippocampus].
[STUDY RELATIVE EXPRESSION OF GENES THAT CONTROL GLUCOSE METABOLISM IN THE LIVER IN MICE WITH DEVELOPMENT OF MELANOCORTIN OBESITY].
Obesity, Maternal
Effects of maternal diet and exercise during pregnancy on glucose metabolism in skeletal muscle and fat of weanling rats.
Insulin stimulates GLUT4 trafficking to the syncytiotrophoblast basal plasma membrane in the human placenta.
Maternal obesity impairs brain glucose metabolism and neural response to hyperglycemia in male rat offspring.
Obesity, Morbid
Decreased adipocyte glucose transporter 4 (GLUT4) and aquaglyceroporin-7 (AQP7) in adults with morbid obesity: possible early markers of metabolic dysfunction.
Ocular Motility Disorders
Glucose Transporter 1 Deficiency: A Treatable Cause of Opsoclonus and Epileptic Myoclonus.
Odontogenic Cysts
Glucose Transporter 1 Expression in Odontogenic Keratocyst, Dentigerous Cyst, and Ameloblastoma: An Immunohistochemical Study.
Immunohistochemical expression of glucose transporter 1 in keratin-producing odontogenic cysts.
Osteoarthritis
Programming changes in GLUT1 mediated the accumulation of AGEs and matrix degradation in the articular cartilage of female adult rats after prenatal caffeine exposure.
Osteosarcoma
Clinicopathological significance of glucose transporter protein-1 overexpression in human osteosarcoma.
Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line.
Glucose transporter 1 expression in canine osteosarcoma.
Glucose transporter protein 1-targeted RNA interference inhibits growth and invasion of the osteosarcoma cell line MG63 in vitro.
Insulin regulates GLUT1-mediated glucose transport in MG-63 human osteosarcoma cells.
Long non-coding RNA HAND2-AS1 targets glucose metabolism and inhibits cancer cell proliferation in osteosarcoma.
MicroRNA-140-5p is Downregulated in Osteosarcoma and Overexpression of MicroRNA-140-5p Inhibits Cancer Cell Proliferation by Downregulating GLUT-1.
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Silencing of Glucose Transporter Protein-1 by RNA Interference Inhibits Human Osteosarcoma Mg63 Cells Growth in vivo.
Ovarian Neoplasms
Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells.
Glucose as a prognostic factor in ovarian carcinoma.
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.
MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.
Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876.
Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.
Overnutrition
Maternal and postnatal overnutrition differentially impact appetite regulators and fuel metabolism.
Overweight
Impact of pre-exercise feeding status on metabolic adaptations to endurance-type exercise training.
Pancreatic Neoplasms
Activated Pancreatic Stellate Cells Enhance the Warburg Effect to Cause the Malignant Development in Chronic Pancreatitis.
Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells.
Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
Glucose and Lactate Transport in Pancreatic Cancer: Glycolytic Metabolism Revisited.
Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.
Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Retraction: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.
Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.
The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor 1? on the uptake of fluorodeoxyglucose ((18)f) in the human pancreatic cancer cell line, patu8988.
Pancreatitis
Pancreatic endocrine function and glucose transporter (GLUT)-2 expression in rat acute pancreatitis.
Pancreatitis, Chronic
Binding forces of hepatic microsomal and plasma membrane proteins in normal and pancreatitic rats: an AFM force spectroscopic study.
Insulin regulation of hepatic glucose transporter protein is impaired in chronic pancreatitis.
Papilloma
Immunohistochemical localization of the glucose transporter GLUT1 in choroid plexus papillomas.
Sinonasal oncocytic Schneiderian papilloma accompanied by intravascular lymphoma: A case report on FDG-PET/CT imaging.
Papilloma, Choroid Plexus
Immunohistochemical localization of the glucose transporter GLUT1 in choroid plexus papillomas.
Papilloma, Intraductal
Glucose transporter expression of intraductal papilloma of the breast detected by fluorodeoxyglucose positron emission tomography.
Papillomavirus Infections
Prognostic significance of hypoxia-inducible factor-1? expression in advanced pharyngeal cancer without human papillomavirus infection.
Paraparesis, Spastic
Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
Parkinson Disease
?-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons.
Unaltered lactate and glucose transporter levels in the MPTP mouse model of Parkinson's disease.
[Glucose metabolism in the basal ganglia]
Peritoneal Fibrosis
[High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Persistent Infection
PPAR?-Mediated Increase in Glucose Availability Sustains Chronic Brucella abortus Infection in Alternatively Activated Macrophages.
Pharyngeal Neoplasms
Prognostic significance of hypoxia-inducible factor-1? expression in advanced pharyngeal cancer without human papillomavirus infection.
Pheochromocytoma
Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Phyllodes Tumor
The expression of metabolism-related proteins in phyllodes tumors.
Pituitary Neoplasms
Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose.
GLUT3 expression in cystic change induced by hypoxia in pituitary adenomas.
Placental Insufficiency
Transcriptomic analysis of equine chorioallantois reveals immune networks and molecular mechanisms involved in nocardioform placentitis.
Pleural Effusion, Malignant
Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: A useful diagnostic tool for malignant pleural effusions.
Pneumonia
Aerobic exercise improves LPS-induced sepsis via regulating the Warburg effect in mice.
Polycystic Ovary Syndrome
Effects of Metformin on the Expression of GLUT4 in Endometrium of Obese Women with Polycystic Ovary Syndrome.
Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients.
Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
Polycythemia
Time-course and reversibility of the hypoxia-induced alterations in cerebral vascularity and cerebral capillary glucose transporter density.
Porphyrias
Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.
Pre-Eclampsia
Placental glucose transporter (GLUT)-1 is down-regulated in preeclampsia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells.
Prediabetic State
Evaluation of the effects of bredemolic acid on selected markers of glucose homeostasis in diet-induced prediabetic rats.
White tea intake prevents prediabetes-induced metabolic dysfunctions in testis and epididymis preserving sperm quality.
Prostatic Neoplasms
EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors.
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.
Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer.
Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancer.
Protein Deficiency
Ketogenic diet for treatment of epilepsy.
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
Docking Studies Show That D-Glucose and Quercetin Slide through the Transporter GLUT1.
Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet.
Glucose Transporter Type I Deficiency Causing Mitochondrial Dysfunction.
GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.
Implications of aberrant temperature-sensitive glucose transport via the glucose transporter deficiency mutant (GLUT1DS) T295M for the alternate-access and fixed-site transport models.
New treatment paradigms in neonatal metabolic epilepsies.
Predicting seizure by modeling synaptic plasticity based on EEG signals - a case study of inherited epilepsy.
[Experience of using ketogenic diet in a patient with glucose transporter 1 deficiency syndrome (a case report)].
[GLUT-1 deficiency syndrome or De Vivo disease: a case report]
[Progresses in studies on the glucose transporter deficiency syndrome]
[Symptomatic absence seizures, the least known causation of absence seizures].
Prurigo
[18 F]-Fluorodeoxy-D-glucose uptake in prurigo nodules induced by the membranous expression of glucose transporter.
Pseudolymphoma
Leptin and its receptor in glucose metabolism of T-cell lymphoma.
Psoriasis
Glucose transporter member 1 is involved in UVB-induced epidermal hyperplasia by enhancing proliferation in epidermal keratinocytes.
Glycoconjugation as a promising treatment strategy for psoriasis.
HIF-1? may promote glycolysis in psoriasis vulgaris via upregulation of CD147 and GLUT1.
Pulmonary Disease, Chronic Obstructive
Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease.
Cellular assessment of muscle in COPD: case studies of two males.
pyruvate dehydrogenase (nadp+) deficiency
Alternating hemiplegia of childhood: metabolic studies in the largest European series of patients.
Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms.
Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases.
Glucose transporter 1 deficiency syndrome and other glycolytic defects.
Ketogenic diet.
Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.
The ketogenic diet: uses in epilepsy and other neurologic illnesses.
Pyruvate Dehydrogenase Complex Deficiency Disease
Alternating hemiplegia of childhood: metabolic studies in the largest European series of patients.
Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms.
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases.
Glucose transporter 1 deficiency syndrome and other glycolytic defects.
Ketogenic diet for treatment of epilepsy.
Ketogenic diet.
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Prospective study of growth and bone mass in Swedish children treated with the modified Atkins diet.
Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.
The ketogenic diet: uses in epilepsy and other neurologic illnesses.
Rectal Neoplasms
Clinical value of significance of Hypoxia Inducible Factor-1?, Glucose Transporter-1 and Carbonic Anhydrase IX in rectal cancer after preoperative chemoradiotherapy.
Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.
Refsum Disease
Laboratory investigations.
Renal Insufficiency, Chronic
Diabetic nephropathy: newer therapeutic perspectives.
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: Impact of the 2020 KDIGO clinical practice guidelines.
Reperfusion Injury
sDR5-Fc inhibits macrophage M1 polarization by blocking the glycolysis.
Respiratory Tract Infections
Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19.
Retinal Degeneration
HIF-1? stabilization reduces retinal degeneration in a mouse model of retinitis pigmentosa.
Retinoblastoma
Differences in the expression of glucose transporter protein isoforms in human retinoblastoma cell lines.
Retinopathy of Prematurity
Retinal neovascular markers in retinopathy of prematurity: aetiological implications.
Rett Syndrome
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Rhabdomyosarcoma
Glucosylated nanomicelles target glucose-avid pediatric patient-derived sarcomas.
Human rhabdomyosarcoma cells retain insulin-regulated glucose transport activity through glucose transporter 1.
PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Rickets, Hypophosphatemic
Mutation analysis of the GLUT2 gene in three unrelated Egyptian families with Fanconi-Bickel syndrome: revisited gene atlas for renumbering.
Salmonella Infections
Understanding the multifaceted roles of the phosphoenolpyruvate: Phosphotransferase system in regulation of Salmonella virulence using a mutant defective in ptsI and crr expression.
Sarcoidosis
HIF-1? regulates IL-1? and IL-17 in sarcoidosis.
Sarcoma
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Glucosylated nanomicelles target glucose-avid pediatric patient-derived sarcomas.
INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
Prognostic impacts of hypoxic markers in soft tissue sarcoma.
Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
The rat facilitated glucose transporter gene. Transformation and serum-stimulated transcription initiate from identical sites.
Sarcoma, Avian
Proteins antigenically related to the human erythrocyte glucose transporter in normal and Rous sarcoma virus-transformed chicken embryo fibroblasts.
Schistosomiasis
Effect of antisense-SGTPs on the glucose uptake of the blood fluke Schistosoma mansoni: observations in adult worms and schistosomula.
In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis.
Scleroderma, Systemic
The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.
Scrapie
Immunogold study of regional differences in the distribution of glucose transporter (GLUT-1) in mouse brain associated with physiological and accelerated aging and scrapie infection.
Quantitative immunogold study of glucose transporter (GLUT-1) in five brain regions of scrapie-infected mice showing obesity and reduced glucose tolerance.
Seizures
A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated hereditary spastic paraplegia.
A Different SLC2A1 Gene Mutation in Glut 1 Deficiency Syndrome: c.734A>C.
A single glucose transporter configuration in normal primate brain endothelium: comparison with resected human brain.
Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
Acute upregulation of blood-brain barrier glucose transporter activity in seizures.
Allelic variations of glut-1 deficiency syndrome: the chinese experience.
Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review.
Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms.
Chronic seizures increase glucose transporter abundance in rat brain.
Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases.
Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome.
Derivative chromosome 1 and GLUT1 deficiency syndrome in a sibling pair.
First report of glucose transporter 1 deficiency syndrome in Korea with a novel splice site mutation.
Functional studies of the T295M mutation causing Glut1 deficiency: glucose efflux preferentially affected by T295M.
Glucose transporter type 1 deficiency: a study of two cases with video-EEG.
Glucose transporter type 1 deficiency: Ketogenic diet in three patients with atypical phenotype.
Glut1 deficiency syndrome: Absence epilepsy and La Soupe du Jour.
Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.
Hypoxic-ischemic brain injury exacerbates neuronal apoptosis and precipitates spontaneous seizures in glucose transporter isoform 3 heterozygous null mice.
Imaging the metabolic footprint of Glut1 deficiency on the brain.
Impaired glucose transport into the brain: the expanding spectrum of glucose transporter type 1 deficiency syndrome.
Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier.
Intractable seizures, developmental delay, and the ketogenic diet.
Ketogenic diet for treatment of epilepsy.
Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome.
Molecular analysis and anticonvulsant therapy in two patients with glucose transporter 1 deficiency syndrome: a successful use of zonisamide for controlling the seizures.
Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders.
New Paradigm for the Treatment of Glucose Transporter 1 Deficiency Syndrome: Low Glycemic Index Diet and Modified High Amylopectin Cornstarch.
New treatment paradigms in neonatal metabolic epilepsies.
Overall cognitive profiles in patients with GLUT1 Deficiency Syndrome.
Pentylenetetrazol-induced status epilepticus up-regulates the expression of glucose transporter mRNAs but not proteins in the immature rat brain.
Phenotypic variability of GLUT1 deficiency: When is necessary to suspect?
Predicting seizure by modeling synaptic plasticity based on EEG signals - a case study of inherited epilepsy.
Rat model of perinatal hypoxic-ischemic brain damage.
Regional analyses of CNS microdialysate glucose and lactate in seizure patients.
Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome.
Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome.
SLC2A1 gene analysis of Japanese patients with glucose transporter 1 deficiency syndrome.
Symptomatic epilepsies imitating idiopathic generalized epilepsies.
The Effects of Ketogenic Diet on Seizures, Cognitive Functions, and Other Neurological Disorders in Classical Phenotype of Glucose Transporter 1 Deficiency Syndrome.
The human brain GLUT1 glucose transporter: ultrastructural localization to the blood-brain barrier endothelia.
The Many Faces of Glut1 Deficiency Syndrome.
Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.
Vulnerability of Left Amygdala to Total Sleep Deprivation and Reversed Circadian Rhythm in Molecular Level: Glut1 as a Metabolic Biomarker.
Sepsis
Alterations of glucose transporter mRNA and protein levels in brain following thermal injury and sepsis in mice.
Shock, Septic
Glucose transporters (GLUT1, 2, & 4) in fat, muscle and liver in a rat model of endotoxic shock.
Short Bowel Syndrome
Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats.
Skin Diseases
Glycoconjugation as a promising treatment strategy for psoriasis.
Sleep Apnea, Obstructive
Association of glucose transporter 4 genetic polymorphisms with obstructive sleep apnea syndrome in Han Chinese general population: a cross-section study.
TNF-? promotes insulin resistance in obstructive sleep apnea-hypopnea syndrome.
[Association of glucose transporter 4 gene polymorphism with hypoxia caused by obstructive sleep apnea syndrome and with related inflammatory factors].
Small Cell Lung Carcinoma
[Expression of GLUT1 protein and its relationship with uptake of FDG in non-small cell lung cancer tissues.]
Spasms, Infantile
Novel and de novo mutations in pediatric refractory epilepsy.
Squamous Cell Carcinoma of Head and Neck
A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer.
Coexpression of hypoxia-inducible factor-1? and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Glucose Transporter 1 Overexpression in Oral Squamous Cell Carcinoma.
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Inhibition of microRNA-218 promotes oral squamous cell carcinoma growth by targeting GLUT1 to affect glucose metabolism.
miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.
Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies.
Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis.
[Expression of glucose transporter 1 in human laryngeal squamous cell carcinoma and its clinical significance].
Starvation
2-Deoxyglucose Impairs Saccharomyces cerevisiae Growth by Stimulating Snf1-Regulated and ?-Arrestin-Mediated Trafficking of Hexose Transporters 1 and 3.
3T3-L1 adipocyte glucose transporter (HepG2 class): sequence and regulation of protein and mRNA expression by insulin, differentiation, and glucose starvation.
A glucose transporter chimera confers a dominant negative glucose starvation phenotype in Saccharomyces cerevisiae.
Chronic treatment with insulin selectively down-regulates cell-surface GLUT4 glucose transporters in 3T3-L1 adipocytes.
Genome-wide identification and characterization of glucose transporter (glut) genes in spotted sea bass (Lateolabrax maculatus) and their regulated hepatic expression during short-term starvation.
Glucose transporter expression and glucose utilization in skeletal muscle and brown adipose tissue during starvation and re-feeding.
Glucose-dependent regulation of glucose transport activity, protein, and mRNA in primary cultures of rat brain glial cells.
Loss of fermentative capacity in baker's yeast can partly be explained by reduced glucose uptake capacity.
Molecular identification of glucose transporter 4: The responsiveness to starvation, glucose, insulin and glucagon on glucose transporter 4 in common carp (Cyprinus carpio L.).
Transcriptional response to glucose starvation and functional analysis of a glucose transporter of Neurospora crassa.
Variable Effects of Autophagy Induction by Trehalose on Herpesviruses Depending on Conditions of Infection.
[The effects of phosphorus, glucose and cytokinin on SEN1 gene expression in Arabidopsis]
Status Epilepticus
Pentylenetetrazol-induced status epilepticus up-regulates the expression of glucose transporter mRNAs but not proteins in the immature rat brain.
Stomach Neoplasms
Correlation and expression analysis of hypoxia-inducible factor 1?, glucose transporter 1 and lactate dehydrogenase 5 in human gastric cancer.
Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells.
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.
Glucose uptake in the human gastric cancer cell line, MKN28, is increased by insulin stimulation.
Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4.
MicroRNA-129-5p Regulates Glycolysis and Cell Proliferation by Targeting the Glucose Transporter SLC2A3 in Gastric Cancer Cells.
p38MAPK Signaling Enhances Glycolysis Through the Up-Regulation of the Glucose Transporter GLUT-4 in Gastric Cancer Cells.
Salidroside induces apoptosis in human gastric cancer cells via the downregulation of ENO1/PKM2/GLUT1 expression.
Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer.
[Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis.]
Stroke
Glucose transporters in brain in health and disease.
Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke.
Stroke, Lacunar
[Immunohistochemistry using antibody to the glucose transporter 3 in human brainstem and cerebellar tissues]
succinate-semialdehyde dehydrogenase [nad(p)+] deficiency
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Thecoma
FDG-PET-positive ovarian thecoma with GLUT5 expression: Five cases.
Thrombocytopenia
Multifocal Lymphangioendotheliomatosis With Thrombocytopenia: Clinical Features and Response to Sirolimus.
Thrombosis
Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in Murine Venous Thrombosis.
Thymoma
18F-FDG PET/CT Evaluation of Thymomas: a Pictorial Review.
Calorie restriction initiated at a young age activates the Akt/PKCzeta/lambda-Glut4 pathway in rat white adipose tissue in an insulin-independent manner.
Expression of Proteasome Subunit ?5t in Thymic Epithelial Tumors.
Extract from Dioscorea batatas ameliorates insulin resistance in mice fed a high-fat diet.
Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats.
Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms.
Thyroid Cancer, Papillary
Association Between (18)F-FDG Avidity and the BRAF Mutation in Papillary Thyroid Carcinoma.
Comparison of (18)F-Fluorodeoxyglucose Uptake with the Expressions of Glucose Transporter Type 1 and Na(+)/I(-) Symporter in Patients with Untreated Papillary Thyroid Carcinoma.
Glycolysis-related protein expression in thyroid cancer.
The BRAF V600E Mutation in Papillary Thyroid Carcinomas Is Associated with Glucose Transporter 1 Overexpression.
Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.
Thyroid Neoplasms
Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Expression of hypoxia inducible factor 1? and 2? and its association with vitamin C level in thyroid lesions.
Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.
Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study.
PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells.
Thyroid Nodule
GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
Tremor
Dystonic tremor caused by mutation of the glucose transporter gene GLUT1.
Triple Negative Breast Neoplasms
Inhibition of miRNA-34a promotes triple negative cancer cell proliferation by promoting glucose uptake.
[Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells].
Tuberculosis
Identification of a glucose permease from Mycobacterium smegmatis mc2 155.
Trehalose limits opportunistic mycobacterial survival during HIV co-infection by reversing HIV-mediated autophagy block.
Tuberous Sclerosis
Therapeutic approach to epileptic encephalopathies.
[The effect of downregulation of MCT1 on the proliferation of glioma cells].
Typhoid Fever
The central metabolism regulator EIIAGlc switches Salmonella from growth arrest to acute virulence through activation of virulence factor secretion.
Urea Cycle Disorders, Inborn
[Dietary advice for treatment of inborn errors of metabolism in adult neurology: principes and limitations]
Uremia
Insulin resistance and altered glucose transporter 4 expression in experimental uremia.
Urinary Bladder Neoplasms
MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.
[Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof]
Uterine Cervical Neoplasms
Correlation Between FDG Uptake by PET/CT and the Expressions of Glucose Transporter Type 1 and Hexokinase II in Cervical Cancer.
GLUT1 expression in human papillomavirus-positive anogenital lesions.
Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy.
Significance of hypoxia in uterine cervical cancer. Multicentre study.
Varicose Veins
GLUT-1 in oral benign vascular lesions.
Vascular Malformations
Congenital vascular malformations--cerebral lesions differ from extracranial lesions by their immune expression of the glucose transporter protein GLUT1.
GLUT-1 in oral benign vascular lesions.
Intraosseous 'haemangioma' of the zygoma: more appropriately termed a venous malformation.
MRI molecular imaging using GLUT1 antibody-Fe3O4 nanoparticles in the hemangioma animal model for differentiating infantile hemangioma from vascular malformation.
Vascular Lesions: GLUT-1 Expression as a Diagnostic Tool to Discriminate Tumors From Malformations.
Vascular Neoplasms
[Posterior mediastinum infantile hemangioma in an 11 months infant, an unusual finding. A case report and review of the literature].
Vesicular Stomatitis
Cellular stress induces a redistribution of the glucose transporter.
Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Virus Diseases
Phosphatidylinositol 3-kinase binding to polyoma virus middle tumor antigen mediates elevation of glucose transport by increasing translocation of the GLUT1 transporter.
Vitamin B 6 Deficiency
Therapeutic approach to epileptic encephalopathies.
Whooping Cough
Glucose transport stimulation by bradykinin in Swiss 3T3 fibroblasts: a pertussis toxin-sensitive mechanism operates without involvement of arachidonic acid and cyclic AMP.
Wilms Tumor
Decreased expression of orexin 1 receptor in adult mice testes during alloxan-induced diabetes mellitus perturbs testicular steroidogenesis and glucose homeostasis.
High NOV/CCN3 expression during high-fat diet pregnancy in mice affects GLUT3 expression and the mTOR pathway.
Microvenular Hemangioma Presenting With Numerous Bilateral Macules, Patches, and Plaques: A Case Report and Review of the Literature.
Xanthomatosis, Cerebrotendinous
Laboratory investigations.
[pyruvate dehydrogenase (acetyl-transferring)]-phosphatase deficiency
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Ketogenic diet for treatment of epilepsy.
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Prospective study of growth and bone mass in Swedish children treated with the modified Atkins diet.